An investigation of the antifungal and antitumor activity of ajoene by Yang, Mandy
 
 
 
 
AN INVESTIGATION OF THE ANTIFUNGAL 
AND ANTITUMOR ACTIVITY OF AJOENE 
A thesis submitted in partial fulfilment of the requirements for the 
Degree 
of Master of Biological Sciences 
in the University of Canterbury 
by Mandy Yang 
University of Canterbury 
2013 
 
 
 
 
 
 
Table of Contents 
Acknowledgements.................................................................................... i 
Abstract .................................................................................................... iii 
Abbreviations ............................................................................................ v 
Chapter 1- Introduction .......................................................................... 1 
Natural therapeutic products ................................................................ 1 
Garlic extract, allicin and ajoene ......................................................... 2 
Antifungal activities of ajoene ............................................................. 3 
Antitumor activities of ajoene ............................................................. 4 
Growth patterns of fungal cancer cells ................................................ 5 
Animal cell growth ............................................................................ 12 
Aim of the study and cell models selected ........................................ 14 
Chapter 2 - Garlic extraction ................................................................ 18 
Introduction ........................................................................................ 18 
Materials ............................................................................................. 20 
Methods .............................................................................................. 20 
Results and discussion for each extraction ........................................ 21 
Conclusion .......................................................................................... 37 
Appendix ............................................................................................ 38 
Chapter 3 - Antifungal activity of ajoene ............................................ 40 
Introduction ........................................................................................ 40 
Materials ............................................................................................. 43 
Methods .............................................................................................. 43 
Results ................................................................................................ 46 
Discussion .......................................................................................... 56 
Conclusion .......................................................................................... 59 
Appendix ............................................................................................ 60 
Chapter 4 – Antitumor activity of ajoene ........................................... 65 
Introduction ........................................................................................ 65 
Materials and Methods....................................................................... 71 
Results ................................................................................................ 82 
Discussion ........................................................................................ 110 
Conclusion ........................................................................................ 115 
Appendix .......................................................................................... 116 
Final conclusions .................................................................................. 121 
References ............................................................................................. 124 
 
 
 
 
i 
 
Acknowledgements 
This work was carried out at the School of Biological Sciences, University of 
Canterbury, New Zealand.   
This Master’s thesis was supposed to be started in 2011, but it was postponed due 
to the Christchurch earthquake and the complications which I experienced during my 
pregnancy. Restarting of the thesis was kindly supported by my supervisor Doctor 
Ashley Garrill in 2012. As a new Mother and a Master’s student, it was always 
challenging to take care of both the little one and my thesis. Fortunately, I received 
consistent warm support from the school and my family, so that I could achieve my 
targets and complete the project with satisfaction.  
I wish to express my sincere gratitude to my supervisors Doctor Ashley Garrill 
and Doctor Kenny Chitcholtan. Working under their supervision has been my pleasure. 
They are knowledgeable mentor to me and they guided me in every aspect of the 
thesis. I have been gaining not only knowledge but also inspiration from them during 
the supervision period.  
I would like to thank my co-supervisors Doctor David Collings and Doctor Andy 
Pratt. Doctor David Collings provided help in imaging, materials for antibodies, and 
advice for my project. Doctor Andy Pratt guided me all the way through the garlic 
extraction with his professional chemistry knowledge. He spent a lot of time on 
teaching me the experimental skills on chemical extraction and on trouble shooting of 
my extraction experiments. I want to thank him from the bottom of my heart.  
I would also like to thank our laboratory technicians and managers, Craig Galilee, 
Jackie Healey and Manfred Ingerfeld. They provided professional technical support 
whenever we demanded.  
Finally to my esteemed colleagues, I received kind help and friendship from 
Tiffany Tan, Emma Swadel, Gloria Adjapong, Abishek Muralidhar, Freddie Prebble 
and Wafaa Hassan.  
 In a word, the help from all of you is very much appreciated.  
ii 
 
  
iii 
 
Abstract 
The garlic extract ajoene is considered to have antimicrobial and antitumor effects 
against a variety of cell types, and it is suggested to have the potential to be used as an 
antifungal or antitumor drug clinically. The underlying mechanism of its inhibitory 
effects is still uncertain. In this project, the effects of ajoene on the growth of fungal 
and oomycete cells were studied on Candida albicans, Neurospora crassa and Achlya 
bisexualis. Endometrial cancer is the most common gynecologic cancer. A 3D 
spheroid model of endometrial cancer cells were for the first time used to investigate 
the antitumor effects of ajoene and selected antitumor agents. Ajoene was extracted 
from fresh garlic by chromatographic methods and the outcome of the extractions was 
verified with Mass spectrometry and NMR spectroscopy. Ajoene was then tested on 
the yeast form or germ tubes of C. albicans, and the cell division and germ tube 
formation was analyzed. N. crassa and A. bisexualis were treated with ajoene on 
plates or on glass slides to measure the hyphae radial extension or individual hyphal 
extension. 3D endometrial adenocarcinoma cell (Ishikawa) spheroids were treated 
with ajoene, paclitaxel, targeted drugs everolimus, sorafenib, gefitinib and canertinib 
alone or in combinations. The growth activity, metabolic activity, cell proliferation, 
apoptotic activity and the cytoskeletons were analyzed after the treatments.  
Cell division of C.albicans was inhibited by ajoene at 5µg/ml or higher concentrations. 
The length of C.albicans germ tubes was significantly shorter in ajoene treated groups 
than the untreated ones. Radial extension and individual hyphal extension of N. crassa 
and A. bisexualis were both inhibited by ajoene. Ajoene did not show any antitumor 
effects on the 3D cell model of Ishikawa cells. No synergistic effect was detected 
between ajoene and paclitaxel or ajoene and everolimus. The targeted drugs 
Canertinib and everolimus showed an inhibitory effect on growth activity of the 
spheroids, but no synergy with paclitaxel. In conclusion, ajoene was able to inhibit 
various forms of fungal and oomycete growth, but any antitumor activity of ajoene 
did not show on 3D culture of endometrial cancer cells.  
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MAPK:  mitogen-activated protein kinase 
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Chapter 1- Introduction 
Natural therapeutic products 
Many natural products are used in traditional herbal medicine or are believed to 
be beneficial to health. The therapeutic effects of these natural products are 
increasingly proven by modern science. For example, leaves of Wedelia chinensis are 
traditionally used in infections and skin diseases. Ethanol and hexane extract of 
Wedelia chinensis leaf were tested on bacterial and fungal species with a disc 
diffusion method, and the extract showed strong inhibitory effects on bacterial strains 
including Staphylococcus aureus and Salmonella typhimurium, and fungal stains 
including Aspergillus niger and Candida albicans (Das, Jeyanthi, & Sharmila, 2013).  
Blechnum orientale leaves are believed to have good medical value for treating 
diarrhoea and stomach problems. The pet-ether, chloroform, methanol and aqueous 
extract of Blechnum orientale fronds were incubated with several bacterial strains in 
96 well plates and with fungal strains in tubes, and the minimum inhibitory 
concentrations were determined after the incubation. The four extracts were able to 
inhibit the growth of Pseudomonas aeruginosa, Escherichia coli and C.albicans 
(Deepa, Parashurama, Krishnappa, & Nataraja, 2013).  
 In Brazil, plants from the Mikania genus have been widely used in the treatment 
of respiratory disorders and many inflammatory diseases. Interestingly, hexane and 
ethanol extracts of Mikania laevigata were tested on two cancer cells lines. For the 
human Larynx carcinoma cell line HEp-2 and cervix adenocarcinoma cell line HeLa, 
and an non-tumor cell line MRC-5, the extracts of Mikania laevigata were found to 
selectively inhibit the proliferation of the cancer cells (Rufatto, Finimundy, 
Roesch-Ely, & Moura, 2013). Another example of a plant with antitumor activity is 
rosemary. The extract of dried Rosmarinus officinalis (Rosemary) leaves have been 
incubated with human colon cancer cells SW620 and DLD-1 in 96 well plates, and 
the rosemary induced cell death was detected by various assays (González-Vallinas et 
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al., 2013). Moreover, the green tea extract EGCG and grape extract resveratrol were 
both found to have antitumor effects on various cancer cell types in vitro and in vivo, 
suggesting the potential of treating cancers with nutraceuticals. (Zlotogorski et al., 
2013).  
 
Garlic extract, allicin and ajoene 
  Of the therapeutic plant extracts, garlic is one of the oldest plants used for 
treatment of diseases and as a heath supplement (Bhandari, 2012). Nowadays, 
scientists are trying to verify the therapeutic effects of garlic by scientific researches 
and it has been confirmed to have antibacterial, antifungal, antivirus, 
immunostimulating and antioxidant activities. The biological activities are thought to 
be due to the abundant active sulfur containing compounds that are found in garlic 
(Iciek, Kwiecień, & Włodek, 2009). There are at least 33 sulfur containing 
compounds in garlic, these include water soluble ones such as S-allylcysteine, and oil 
soluble ones such as allicin (allyl 2-propenethiosulfinate) (Bhandari, 2012; Iciek et al., 
2009). Allicin does not exist in intact garlic bulbs. It is produced during the crushing 
of garlic.  
Allicin has been confirmed to be the most biologically active compound among 
the sulfur containing compounds in garlic. It has antimicrobial activities towards a 
variety of microorganisms, such as the bacterial strains Escherichia coli and 
Staphyloccocus aureus (Ankri & Mirelman, 1999), and fungal strains C.albicans and 
Trichophyton rubrum (Aala, Yusuf, Jamal, & Khodavandi, 2010; Guo et al., 2010). 
Unfortunately, allicin is very unstable at normal body temperature (Freeman & 
Kodera, 1995). Therefore, allicin may not be responsible for therapeutic effects of 
garlic and the instability of allicin has limited its use as a potential treatment of 
diseases.  
 Ajoene (4,5,9-thrithiadodeca-1,6,11-triene 9-oxide), which is one of the 
degradation products of allicin, is suggested to be more stable and have 
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antithrombotic, antifungal and antitumor activities (Block et al., 1984; Erkoc, Sumerb, 
& Erkoc, 2003; Naganawa et al., 1996). It is a mixture of two isomers, Z-ajoene and 
E-ajoene, and it can be obtained from garlic by mixing garlic with edible oils.  
 
Antifungal activities of ajoene 
Fungal infections in healthy humans are mostly caused by a limited number of 
fungal species. The majority of fungal species that cause disease will do so mostly on 
immunocompromised individuals. For example, Candida infections and mould 
infections, such as Aspergillus infections and some environmental filamentous fungi, 
are common major causes of severe infections on susceptible bodies, unfortunately a 
lot of the moulds are resistant to commonly used antifungal drugs (Araujo, Pina-Vaz, 
& Rodrigues, 2010). Ajoene has shown inhibitory effects against a broad spectrum of 
fungal species in vitro, in vivo and in clinical trials, and it has a potential to be used as 
a novel antifungal drug in the clinic. In 1987, Yoshida’s group incubated A. niger and 
C.albicans with ajoene or allicin on Sabouraud medium and the fungal growth was 
assessed by measuring the dry weight of the culture after incubation. The authors 
found that ajoene exhibited stronger antifungal effects against these two 
microorganisms than allicin. The effects of ajoene on hyphae of A.niger were further 
observed by scanning and transmission electronic microscopy. The authors suggested 
that ajoene was able to induce hyphae surface depression and the detachment between 
cell membrane and cell wall (S. Yoshida et al., 1987).  
Maluf’s group infected mice with Paracoccidioides brasiliensis, and the mice 
were then treated with synthesized ajoene by intraperitoneal injection. After the 
treatment, ajoene reduced the levels of anti-P. brasiliensis antibodies and reversed the  
symptoms of P. brasiliensis infection which included granulomas in the spleen, liver 
and abdominal cavity (Maluf et al., 2008).  
 Ajoene has also shown its ability to be effective against fungal infection in 
humans. The fungus Cladophialophora carrionii causes chromoblastomycosis in 
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humans. The disease is one of the most common mycosis in tropical areas, and causes 
localized lesions on skin and subcutaneous tissues. The lesions can be classified into 
several types, nodular, tumorous, verrucous, plaque and scarring. The severe cases of 
the infection may cause a combination of more than one types of lesions and 
spreading of the fungus into the blood or lymphatic vessels. Perez-Blanco et al. (2003) 
treated two groups of patients who had localized lesions by applying gel containing 
0.5% ajoene or gel containing 1% 5-fluorouracil on the skin, and the cure rate was 
comparable between these two groups. The ajoene treated group had less skin damage 
and lower rates of relapse (Pérez-Blanco, Valles, Zeppenfeldt, & Apitz-Castro, 2003).  
 
Antitumor activities of ajoene 
 Besides antifungal activity, ajoene is also believed to have antitumor activity. 
Cancer is one of the most public concerning diseases (Milner & Romagnolo, 2010). It 
is ranked as the second cause of health loss (after cardiovascular disease) in the world 
(Soeberg, 2012). The antitumor activity of ajoene has been tested on many cancer cell 
lines in vitro and solid tumors in vivo. For example, it is able to cause cell death to 
human promyelocytic leukemia HL-60 cell line by inducing reactive oxygen species 
and activation of apoptosis (Dirsch, Gerbes, & Vollmar, 1998). Li et al. (2002) used 
Z-ajoene for treating nasopharyngeal carcinoma cell line, promyelocytic leukemia 
HL-60 cell line, and several other cells lines in vitro, the growth of the cancer cells 
were inhibited significantly, and the HL-60 cancer cells were arrested at G2/M phase 
of their cell cycle. The authors then tested the in vitro effects of ajoene on tubulin, and 
the tubulin assembly was blocked by ajoene in a dose dependent manner (Li et al., 
2002). Taylor’s group induced melanoma tumor on mice by injection of melanoma 
cells, and ajoene was injected afterwards to treat the metastatic and primary tumors. 
The number of metastases in lung and the size of the primary tumor were both 
reduced significantly by ajoene (Taylor et al., 2006). Furthermore, twenty one patients 
with skin cancer basal cell carcinoma were treated with ajoene by applying ajoene 
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cream on their affected skin, and the local application of ajoene reduced the tumor 
size in 17 of the 21 patients (Tilli et al., 2003).  
 
Growth patterns of fungal cancer cells 
The underlying mechanism of the antifungal and antitumor activity of ajoene is 
still uncertain. Fungal cells and tumor cells are two distinct cell types, and they 
employ various growth patterns.  
 
Apical growth of fungal and oomycete cells 
Fungal cell growth can be divided into two types, the apical form of growth and 
the yeast form of growth. Apical growth (tip growth) is the extension of the 
predominant vegetative cell form of fungi, the hypha. It is a form of growth displayed 
in oomycete hyphae, root hair cells, algal zygotes and pollen tubes. The apical growth 
of hyphae can be described as the continuous extension of the plastic and deformable 
tip (the extension zone), with locally synthesized cell wall components. When the 
hypha is growing, the formed hyphal part ages and does not grow, and the growth 
only occurs on the tip or at a branching point. When a hypha extends, the viscoelastic 
cell wall at the hypha tip is synthesized at the same rate as the extension. Materials 
required for the new wall synthesis are continuously delivered to the tip of hypha by 
vesicles and other cytoplasmic components. The cytoplasm is drawn towards the tip 
while the hypha grows (Deacon, 2009).  
Analysis of the ultrastructure of fungal hyphae further confirmed the pattern of 
apical growth (Fig.1.1). The arrangement of fungal organelles from the tip to the base 
of a hypha shows a clear polarity. The tip end contains a cluster of vesicles and they 
are moved to the tip when hypha extends. The vesicles contain materials for cell wall 
synthesis including chitin and glucan synthase, and the cluster of vesicles is termed 
the SpitzenkÖrper. Sub-apical to this, there is a mitochondria rich zone which is 
thought to be responsible for providing the energy for movement of nutrients to the tip. 
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Further back is the branched tubular vacuoles zone which may be responsible for 
transporting the metabolites (Deacon, 2009).  
 
 
 
 
 
 
 
Figure 1.1. Hypha extension model of filamentous organisms.  Vesicles are 
transported to the cell apex and form a cluster that function in wall synthesis. The cell 
wall at the cell apex is considered to be softer and with less crosslinks than the wall 
further back.  
M: microtubule associated motor proteins 
V: Vesicles which are transported to the hyphal tip by cytoskeleton. 
The image is reproduced from Deacon, J. W. (Deacon, 2009) 
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The driven force of the tip growth is suggested to be related to turgor pressure at 
the tip and possibly cytoskeletal components (microtubules and actin filaments) 
(Deacon, 2009). Turgor pressure is the internal hydrostatic pressure which provides a 
force that drives cellular expansion. Turgor is created by osmosis that occurs in 
response to the concentrations of osmotically active substances being higher within 
the cell than in the surrounding environment. During the process of cell growth, the 
cell expands as a result of water flow and the cell wall is continuously restructured to 
response to the volume and pressure change. In order to regulate and maintain the 
turgor pressure under a changing extracellular environment, the osmolyte synthesis 
and ion accumulation are possibly regulated by osmotic mitogen-activated protein 
kinase (MAPK) pathway (Lew, 2011). However, there are some evidence that turgor 
does not play a role as the driven force of growth in some hyphal cells. For example, 
oomycetes Achlya bisexualis and Saprolegnia ferax have been found to be able to 
grow without a measureable turgor (Money & Harold, 1993); and a slime variant of 
Neurospora crassa was found to be able to grow in the absence of cell wall (Emerson, 
1964). Thus, for these hyphal cells, it is suggested that cell growth may be mainly 
driven by cytoskeletal components (Deacon, 2009). 
 
Role of the cytoskeleton in apical growth 
Microtubules and actin filaments are components of the cytoskeleton which exist 
in all eukaryotic cells. They have important roles in cell growth, division, shape 
maintenance, vesicle transport and movement. Microtubules are composed of multiple 
protofilaments, which are formed by tubulin heterodimers joining head to tail. The 
protofilaments are assembled to form the helical cylinder wall that makes a 
microtubule. As the tubulin subunits are α and β tubulin heterodimers, the assembled 
microtubules are polarized, with the β end termed the plus end and α end termed the 
minus end. The microtubules are dynamic, which means the length, location and 
number of them can be changed easily by addition or disassociation of tubulin 
subunits to/from the microtubules. The addition of subunits tends to take place at the 
plus end and the disassociation of subunits tends to take place at the minus end. Actin 
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filaments are formed by two parallel protofilaments that twist around each other. The 
actin subunits which form actin protofilaments are monomers. Similar to microtubules, 
actin subunits also join head to tail to generate a polarized actin filament, and the 
addition of subunits tends to happen at the plus end (Alberts et al., 2002). 
In polarized apical growth, dynamic microtubules and actin filaments are thought 
to be crucial for establishing and maintaining cell polarity for the growth process, and 
also are required for delivering the vesicles for polarized cell extension. Microtubules 
are thought to deliver the “cell end marker” proteins to cell pole, in order to organize 
the actin cytoskeleton for subsequent transport of vesicles to the cell end (Fischer, 
Zekert, & Takeshita, 2008). It is also possible that in low turgor cells, the actin 
cytoskeleton could provide a protrusive force at the tip (Heath & Steinberg, 1999). 
 
Yeast form growth in fungi 
 In the other form of fungal growth, yeast growth, the fungal cells employ a 
repeated “budding” (or fission) process to produce single cells. The young cell is 
called a daughter cell and the cell which it originates from is called the mother cell. In 
the beginning, daughter cells bud from a designated position on the mother cell by 
channeling of the cell wall components to the bud tip. DNA synthesis and duplication 
of the mother nucleus is processed by mitosis (the process of mitosis will be explained 
in the later paragraphs) when the budding process starts. When the wall components 
are uniformly formed for the daughter cell by the mother, one of the nuclei enters the 
daughter cell, and cytokinesis starts to separate them into two single cells. The 
budding process is also a form of polarized growth (Fig.1.2). When mother cell 
develops the first bud, it emerges at one of the poles of the mother cell, and initially 
the bud grows in a polar manner towards the upper pole of the daughter cell. After the 
first daughter cell is separated from the mother cell, there is a scar left on the first 
budding point. The point for the next bud will be adjacent to the scar, and there will 
be a mark and a ring of septin proteins placed on the new point before the second 
budding, so that the actin filaments and septum can be directed to this point rapidly 
for the second budding. During the whole process, many of the cellular components 
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arrange asymmetrically. Some yeast cells grow in the way of fission, which means 
that the yeast cells are cylindrical and they extend in both ends. The cells divide when 
they reach a critical volume (Deacon, 2009).  
 
 
 
 
 
 
 
 
Figure 1.2.  The polarized budding process of yeast.  
a. A yeast cell.  b. The mother cell is preparing for budding on the planed budding 
point. c. Emergence of the bud tip on the budding point.  d. Initially the bud grows 
towards its upper pole.  e. As the bud grows to a critical size, wall expansion 
happens in all directions of the bud.  f. A septin ring is formed between the daughter 
and mother cells.  g. The daughter cell is separated from the mother cell.  
The drawing is reproduced from Deacon, J. W. (Deacon, 2009) 
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Role of cytoskeleton in yeast form growth 
 Microtubules and actin filaments are important in yeast cell polarity and the 
processes of budding and fission. In addition, during mitosis of cells, microtubules 
and actin filaments are assembled specially. After the chromosomes are replicated, the 
microtubules and accessory proteins are assembled to form bipolar mitotic spindles, 
and they separate the chromosomes and allocate one copy to each daughter cell. Then 
the actin filaments and myosins form a contractile ring or cell plate that facilitates cell 
division (Alberts et al., 2002).   
 
Germ tube formation 
  Some fungi, such as C. albicans, can grow in both a yeast and a hyphal form. 
These fungi are called dimorphic fungi and the dimorphism allows them to adapt to 
various environmental conditions (Ruiz-Herrera, 2012). The transition of cell growth 
from a budding to a hyphal form is recognized by a phenomenon called germ tube 
formation, as a young hypha like tube extended from yeast cell (Munin, Giroldo, 
Alves, & Costa, 2007).  
Fig. 1.3 shows the cell cycle that underlies the germ tube formation. The germ 
tube extends through a band of septin proteins. The polarisome and Spitzenkörper 
initially drive the polarized extension of the germ tube. When the germ tube extends 
to a certain length, a septin ring forms and the spindle body, which is responsible for 
the separation of chromosomes, is duplicated at this time. The septin ring then travels 
down and the nuclei travels up together with short spindles to the position of septin 
ring. The movement of nuclei is facilitated by microtubules. After the chromosomes 
are condensed, the spindles elongate to drag the chromosomes apart, one to the newly 
formed germ tube, the other to the basal cell. Finally, the septin ring constricts the 
cells and there is a septum formed between the hypha and basal cell to separate the 
two cells. However, the two cells are still attached (Gladfelter & Berman, 2009).  
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Figure 1.3.  The process of germ tube formation and cell division.  
a. The cell prepares for germ tube formation by DNA replication and reproduction of 
cytoplasmic components. The septin band forms at the boundary between the germ 
tube and basal cell.  b. The septin ring and new spindle body form. The septin ring 
and nuclei travel towards each other.  c. Nuclei travel to the position of septin ring.  
d. and e. Spindles drag the chromosomes apart and the nuclei are separated, and the 
spindles are dissolved after the process. f. Cells are separated by septin ring and the 
wall materials form between the new hypha and basal cells. 
The figure is reproduced from Gladfelter & Berman (2009). (Gladfelter & Berman, 
2009) 
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Animal cell growth 
Cell cycle in normal and cancer cells 
Somatic animal cells including cancer cells reproduce by division. The time of 
the process from the start point when a cell is generated from its mother cell to its 
own division is termed the cell cycle. The cell cycle can be divided into two periods, 
interphase and mitosis. Interphase covers almost 90% of the cell cycle, and it is a 
period for synthesis and growth. It can be further divided into 3 phases, G1 (first gap), 
S (synthesis) and G2 (second gap). Chromosomes of the cell are replicated in S phase 
and the proteins and cytoplasmic components are reproduced during the whole 
interphase (Alberts et al., 2002).  
Mitosis (M) is the period during which the cell divides, and it is further divided 
into prophase, prometaphase, metaphase, anaphase, telophase and cytokinesis. During 
prophase and prometaphase, the replicated chromosomes condense and are released 
from the nuclear envelope. Then in the later phases, the microtubules formed mitotic 
spindles attach the kinetochores of the chromosomes and pull the chromosomes to the 
spindle poles. In telophase, the chromosomes de-condense and a new nuclear 
envelope forms, so that each nucleus contains one copy of the genome. In the final 
stages of division, actin filaments and myosin constrict the middle of the cell and 
clave the cell into two daughter cells (Bolsover, Shephard, White, & Hyams, 2011).  
 
Cancer cells have the feature of continuous division and an absolute proliferative 
rate. In normal cells, the cell cycle is regulated by cell cycle regulators during 
interphase. Normal cells can respond to extracellular signals through the regulators at 
G1 phase and exit from the cell cycle by entering G0 (resting) phase. In contrast, 
cancer cells have a perturbed G1 checkpoint control, and cell cycle exit is prevented 
by overriding the regulators and pathways, such as mutation on cell cycle regulation 
gene P53. Therefore, cancer cells are unable to exit the cell cycle (Sherr, 1996).  
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Cell death in normal and cancer cells 
In animal organs, homeostasis is maintained through the elimination of 
unnecessary cells by cell death. Apoptosis is one important type of cell death, and it is 
characterized by cytoplasmic shrinkage, membrane blebbing, chromatin condensation, 
nuclear fragmentation, DNA fragmentation, and the formation of apoptotic bodies 
with cytoplasmic content. There is no inflammation involved in this type of cell death. 
Caspases, which are cysteine-dependent aspartic acid-specific proteases, are  the 
most important compounds responsible for apoptosis. During apoptosis, caspases 
cleave vital cellular substrates, therefore inducing cell death (Reimann & Schmitt, 
2007).  
The activation of apoptosis is suggested to be mainly achieved by either extrinsic 
or intrinsic signals. The extrinsic signal is released by the activation of cytoplasmic 
membrane based death receptors and their downstream caspases. DNA damage and 
cytotoxic drugs induce intrinsic signals that are mediated by the mitochondria. The 
B-cell lymphoma/leukemia-2 (Bcl-2) protein regulators destabilize the mitochondria, 
and then the mitochondria release cytochrome-c and subsequently cause 
the oligomerization of apoptotic protease activating factor 1 (Apaf-1) and formation 
of apoptosome. The apoptosome can then activate caspases and induce proteolysis to 
the cell (Reimann & Schmitt, 2007). 
Continuous proliferation and suppressed apoptosis are common events in cancer 
progression. To achieve these, cancer cells have altered survival signaling pathways 
such as deregulated expression of the survival factors, activating mutations of survival 
signal inducer Akt (a serine/threonine specific protein kinase), or mutation on Akt 
suppression associated PTEN. Some cancer types are found to be able to overexpress 
some anti-apoptotic proteins and stabilize the mitochondria. Moreover, loss of Apaf-1 
is also suggested in some tumors as a way of apoptosis suppression (Evan & Vousden, 
2001).  
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Aim of the study and cell models selected 
Aims and cells 
As stated previously, the underlying mechanism of the effects of ajoene on fungal 
and tumor growth is still unsure. The mostly supported hypotheses are microtubule 
assembly inhibition and oxidative stress induction, or both (Dirsch et al., 1998; Li et 
al., 2002; Scharfenberg, Wagner, & Wagner, 1990). Disulfide bonds in ajoene are 
believed to be the central structure responsible for its biological activity (Kaschula et 
al., 2012).  
In the present project, ajoene’s antifungal and antitumor activities were studied. 
In order to investigate the effects of ajoene on yeast and hyphal forms growth, ajoene 
was used to treat yeast and germ tube form C. albicans, and hyphae of A. bisexualis 
and Neurospora crassa. Its antitumor activity was tested by treating human 
endometrial adenocarcinoma cancer with ajoene in vitro.  
 
Endometrial cancer 
Human endometrial is the seventh most common malignant disorder worldwide, 
and is the commonest cancer of the female genital tract in developed countries 
(Amant, Moerman, Neven, & Timmerman, 2005). Most cases are diagnosed when 
vaginal bleeding after the menopause is reported. For patients who are diagnosed at an 
early stage of endometrial cancer, hysterectomy (surgical removal of tumor) is 
curative. However, advanced stage and high grade endometrial cancers have a poor 
prognosis (Leslie, Thiel, & Yang, 2012).  
There are different means of classification in endometrial cancer. The disease can 
be divided into several stages according to the histopathology, or two subtypes based 
on the underlying pathogenesis. Type-I is normally a lower grade cancer and it is 
believed to be estrogen related (Leslie et al., 2012). The structure and cells of the 
human endometrium change in response to fluctuations of estrogen and progesterone 
during the menstrual cycle. Long term exposure to estrogen induces endometrial 
hyperplasia, and increases the chance of development of type-I endometrial cancer 
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(Amant et al., 2005). The type-I endometrial cancer is frequently found to have 
mutations of the cell proliferation marker Akt suppressor PTEN. The type-II 
endometrial cancer is poorly differentiated and often high grade, and it has been 
suggested to be estrogen-independent. The mutations frequently associated with 
type-II endometrial cancer are of the cell cycle regulator p53 (Leslie et al., 2012).  
Chemotherapy is used for the treatment of the metastatic stage of the disease. 
Drugs clinically used for chemotherapy are still limited to cytotoxic drugs which 
induce apoptosis in the cells (Markman, 2007). Targeted therapy using growth factor 
inhibitors has also shown beneficial effects in clinical trials, but is still under 
investigation (Leslie et al., 2012). In this study, ajoene was tested on a 3D endometrial 
cancer cell culture not only by the use of it alone, but also in combination with 
cytotoxic and targeted drugs. The aim of using the combination was to detect any 
additional or synergistic effects between these drugs.  
 
3D cancer cell culture 
The cancer cell culture we used in this study was 3D spheroid model. When 
cancer cells are cultured on an adherent surface, they form 2D monolayers which 
adhere to the surface. By contrast, cancer cells undergo spontaneous homotypic 
aggregation on non-adherent surfaces (Chitcholtan, Asselin, Parent, Sykes, & Evans, 
2013). These multicellular structured tumor spheroids are believed to be closely 
associated with solid tumors. Intercellular adhesion within the spheroids is achieved 
by interactions between cadherin proteins. Adjacent cells in the spheroids can be 
connected by gap connections, which allow exchange of cytoplasmic components 
between the cells. It is suggested that in a 3D spheroid culture, intercellular signaling 
pathways are able to regulate cell survival and apoptosis resistance. Although the 
model has only been used in in vitro tumor experiments recently, the 3D spheroid 
culture is believed to be more accurately mimic the in vivo growth and 
microenvironments of tumors (Bates, Edwards, & Yates, 2000).  
 
 
16 
 
 
In the following chapters, the detailed extraction of ajoene, antifungal 
experiments and antitumor experiments will be explained and discussed separately. 
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Chapter 2 - Garlic extraction 
Introduction 
Ajoene (4,5,9-thrithiadodeca-1,6,11-triene 9-oxide, C9H14OS3, scheme 2.1) 
was firstly discovered and extracted from garlic by Block’s research group in 1986. It 
is a mixture of two isomers, E isomer and Z isomer (Block, Ahmad, Catalfamo, Jain, 
& Apitz-Castrozd, 1986). Garlic contains a considerable high amount of alliin 
(S-allylcysteine S-oxide) and an enzyme allinase, which can convert alliin to allicin 
(allyl 2-propenethiosulfinate) at room temperature (Block et al., 1984). Block’s group 
reported that allicin would then undergo a slow decomposition at room temperature 
and yield ajoene. To test their hypothesis, they obtained ajoene by extraction from 
fresh garlic and also by synthesizing it from allicin. In their methods of extraction, 
they mixed garlic with methanol and extracted it with organic solvents based on the 
polarity of the compound of interest, and the final separation was achieved by flash 
chromatography (Block et al., 1986).  
Since the discovery of ajoene, there are numerous reports that suggest 
antithrombotic and antimicrobial activities of ajoene (Block et al., 1984; Naganawa et 
al., 1996; San-Blas, San-Blas, Gil, Marino, & Apitz-Castro, 1989). Increasing 
numbers of scientific communities have shown particular interests in the biological 
activity of ajoene and attempted to extract and purify it from garlic. Yoshida and 
co-workers for example extracted ajoene from garlic and tested it on various 
microbial organisms (S. Yoshida et al., 1987). It was suggested that ajoene could be 
extracted by mixing garlic with rape seed oil and this was further purified with HPLC 
(H. Yoshida et al., 1998). Recently, scientists also managed to extract ajoene from 
garlic by mixing garlic with ethanol or animal lipids (Kay et al., 2010; Shin et al., 
2012). Currently, there is no analytical grade ajoene or allicin commercially available 
for research purposes. Therefore, in this project, ajoene was extracted from fresh local 
garlic using the methods described by Block’s research group. The results presented 
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here were obtained from four independent experiments.  
 
 
 
 
 
 
 
 
Scheme 2.1. The skeletal structures of Z and E isomers of ajoene (Block et al., 1986).   
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Materials 
Fresh New Zealand garlic was obtained from the local supermarket Count 
Down on Riccarton Road, Christchurch. Analytical grade organic solvents including 
methanol, ether, pentane, methylene chloride and ethyl acetate were purchased from 
Ajax Chemicals Limited (New Zealand). Silica gel 60, which had a 230-400 mesh, 
was purchased from Sigma-Aldrich Limited (New Zealand). 
Methods 
For each extraction, six hundred grams (600 g) of fresh New Zealand garlic 
was peeled and mashed. The mashed garlic was soaked in 1 L of methanol and then 
placed on an orbited shaker set at 70rpm at 20°C for 72 hours. The methanol was 
removed every 24 hours during the incubation. The removed methanol was combined 
to give 3 L of methanol, which was then filtered to remove any solid materials, and 
the filtrate was then concentrated with a rotary evaporator to obtain the amount of 100 
ml. The concentrated soluble material was then purified with ether, pentene and 
methylene chloride to remove unwanted compounds, and finally the partial purified 
solution, which was the methylene chloride extract, was subjected to silica/ ethyl 
acetate flash chromatography for further separation. 
Silica gel 60 was placed in a 15cm x 2cm column and packed with ethyl 
acetate. The partial purified crude extract was loaded on the silica gel and eluted with 
ethyl acetate under pressure. Twenty four to 30 fractions of eluate were collected and 
tested with thin layer chromatography (TLC). The presence of active compounds was 
observed under ultra violet (UV) light. The active fractions which had same retention 
time on silica gel/ethyl acetate TLC were combined and tested using mass 
spectrometry (MS, acquisition parameters are shown in appendix 2.1) and NMR 
spectroscopy to detect the presence of ajoene. The fraction which contained ajoene 
was evaporated to remove any solvent. The ajoene oil was diluted to 5 mg/ml with 10% 
DMSO (dimethylsulfoxide) and stored at -20°C (Dirsch et al., 1998). The stock 
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solution was further diluted with phosphate buffer saline (PBS) before being used for 
in vitro manipulations. 
Results and discussion for each extraction 
In this project, I extracted ajoene from four independent attempts. The results 
of these extractions were somewhat variable as described below.  
 
First extraction 
In this extraction, after washing with organic solvents, 0.32 g of crude material 
was subjected to silica gel/ethyl acetate flash chromatography. Twenty four tubes of 
fractions were collected from flash chromatography.  The fractions which quenched 
UV light were tested on TLC, and the eluates showing the same retention time were 
combined. The TLC plate of the active fractions from this extraction was shown in 
Fig.2.1. Based on the similarity of retention times on the TLC plate, the fractions tube 
4 and 5 were combined and tube 7 was combined with tube 8. Fraction tube 10 was 
combined with 11. Fraction tube 12 was combined with 13, 14 and 15. These 
combinations were then tested using MS and NMR spectroscopy. Ajoene was detected 
in the combined fractions 7- 8. The MS for fractions 7- 8 is shown in Fig.2.2 and the 
NMR spectroscopy data is shown in Fig.2.3.  
The mass spectrometer created charged particles (ions which are H
+ 
and Na
+
 
forms of ajoene) from ajoene molecules. The ions were then analyzed by measuring 
the mass/charge ratio to provide information about the molecular weight of the 
compound (University of Arizona). The molecular weight of ajoene is 234.4, and H
+ 
and Na
+ 
forms of ajoene were detected in fractions 7-8 with a molecular weight of 
235.0277 and 257.0099. Therefore, the composition of this compound was confirmed 
by MS to be consistent with the composition of ajoene.  
NMR spectroscopy measures the resonant frequencies of the nuclei in the 
compounds and provides structural information about the compound. The distinct 
peaks of cis and trans ajoene were identified by NMR and common peaks were also 
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displayed on the result (Fig 2.3). The NMR data was consistent with the NMR data of 
ajoene in literature. Therefore, the structure of the compound in fractions 7-8 
represented a mixture of E and Z isomers of ajoene. 
Based on these results, ajoene appeared to be present in the fractions that had 
moderate elution rates (Fig 2.1). There were still some impurities as shown in NMR 
spectroscopy result (Fig 2.3), but they were unlikely to affect the activity of the ajoene. 
Therefore, the solute in tubes 7-8, which had a final weight of 10mg, was diluted with 
DMSO and used in subsequent antifungal and antitumor experiments. The garlic 
extract from first extraction will be termed “1GE” in the following chapters. 
 
 
  
Figure 2.1.  TLC plate of the fractions collected from flash chromatography for the 
first garlic extraction. On this plate, Fractions 4 and 5; fractions 7 and 8; fractions 10 
and 11; and fractions 12, 13, 14 and 15 were combined respectively and tested using 
MS. Fractions 7-8 combination was found to contain ajoene based on the MS data. 
 
Ajoene positive 
Spotting line 
       3    4    5       6    7    8    9    10  11     12  13   14 
Fraction number 
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Figure 2.2.   Mass spectrum of fractions 7-8 of the first extraction.  Ajoene was 
detected in H
+ 
and Na
+ 
form. The detection of ajoene was based on the molar mass of 
the compounds. The molar mass of ajoene is 234.4. In mass spectrometry, ajoene 
molecule was ionized in H
+ 
or Na
+ 
form, the molar mass 235.0277 and 257.0099 
agreed with the H
+ 
and Na
+ 
form of ajoene.  
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Figure 2.3.   NMR spectroscopy data of tube 7-8 fractions. Two isomers of ajoene 
were detected by NMR. The Z isomer and E isomer had common peaks at 5-6 ppm 
and 3.2-3.6 ppm (black circles), and distinct peak for the double bond of which 6.55 
ppm for Z and 6.38 ppm for E isomers (red circles). This data was consistent with the 
literature from Block’s group on extraction of ajoene from garlic (Block et al., 1986). 
Therefore, the structure of the compound in our garlic extract was confirmed to be 
consistent with the structure of ajoene. 
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Second extraction 
After washing with organic solvents, the methylene chloride extract was 
spotted on to a TLC plate to test the components before it was subjected to flash 
chromatography. This TLC plate of the crude material from this extraction is shown in 
Fig.2.4. 0.44 g of crude material was subjected to silica gel/ethyl acetate flash 
chromatography. Thirty fractions were collected after elution. The fractions were 
tested with TLC but there was no moderate elution rate compound detected. After 
washing the column with 1:9 methanol/ethyl acetate, an additional 30 tubes were 
collected and the contents of fractions 4-6, 9, 10, 11-12, 13, 19-24 were tested with 
MS. No ajoene was detected in any of these fractions. However, there was some 
material that had a moderate travelling rate showed on the TLC plate before flash 
chromatography (Fig.2.4). The size of column used in the first extraction was 15 cm 
in height and 2 cm in width as detailed, whereas the column used in the second 
extraction was 40 cm in height and 1.5 cm in width. The pressure used for the second 
column was much lower than the first extraction. According to Van Deemter’s curve, 
the influence of diffusion to the result of separation will be increased largely if the 
flow rate is too slow (Van Deemter & Zuiderweg, 1956). The extremely slow rate also 
resulted in an interruption of flow during the night which could also have caused 
failure of elution of the compound. It is possible that the moderate elution rate 
material was trapped in the column and it was not eluted off, even after the increasing 
of the polarity of the mobile phase. 
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Figure 2.4.  TLC plate of the methylene chloride extract from the second extraction. 
A small amount of the extract was spotted on the TLC and the TLC was run with ethyl 
acetate. The plate showed that there were fast, moderate and slow materials on TLC. 
But the moderate material was not detected by MS after the chromatography. 
 
 
 
 
 
 
 
 
 
Spotting point 
Moderate rate 
Fast rate 
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Third extraction 
After washing with organic solvents, 0.78 g of crude material was subjected to 
silica gel/ethyl acetate flash chromatography. Thirty fractions were collected after 
elution. All fractions which quenched UV light were tested on TLC and eluates which 
had same retention time were combined. The TLC plate is shown in Fig.2.5. Fractions 
3 to 17 were tested using MS. Ajoene was detected from fractions 5 to 7 and from 
fractions 8-12. The Mass spectrum reports of positive tubes are shown in Fig.2.6 to 
Fig.2.10. 
Based on the TLC (Fig.2.5) and MS data (Fig.2.6-2.10), fraction 5 can be seen 
to have a small amount of ajoene and the concentration of ajoene increased in the 
subsequent tubes and then was absent in fraction 13. This result agreed with the TLC 
pattern of the moderate travelling rate material marked red on Fig.2.5. Therefore, we 
could confirm ajoene’s position on TLC plate based on these results (Fig.2.5). This 
was used as a quick indicator for the presence of ajoene on the TLC plate of the next 
extraction. 
The final weight of the yellow oil in fractions 5-7 was 0.12g after evaporating 
the solvent. The yellow oil was then diluted with DMSO and used in antifungal and 
antitumor experiments. This extract will be termed “3GE” in the following chapters. 
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Figure 2.5.  The TLC plate of the fractions collected from flash chromatography for 
the third garlic extraction. On this plate, fractions 5-7, 8-12, and 13-17 appeared to 
have compounds which travelled at the same rate on silica gel. These fractions were 
combined and tested using MS. The MS data showed that the 7-8 fractions had most 
of the ajoene. 
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Figure 2.6.  Mass spectrum of fraction 5 of the third extraction. Ajoene was detected 
in the Na
+
 form (shown in red circle, C9H14NaOS3) in a small amount. 
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Figure 2.7.  Mass spectrum of fraction 7 from the third extraction. Ajoene was 
detected in the Na
+ 
form (molar mass 257.0099).  
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Figure 2.8.  Mass spectrum of fraction 9 from third extraction. Ajoene was detected 
in the Na
+ 
form (red circle molar mass 257.0101).   
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Figure 2.9.  Mass spectrum of fraction 11 from third extraction. Ajoene was detected 
in the Na
+ 
form (red circle, molar mass 257.0098).   
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Figure 2.10.   Mass spectrum of fraction 13 from the third extraction. Ajoene was 
not detected.  
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Fourth extraction 
After washing with organic solvents, 0.56 g of crude material was subjected to 
silica gel/ethyl acetate flash chromatography. Twenty four fractions were collected 
after elution. Again all fractions which quenched UV light were tested on TLC and 
eluates which had the same retention time were combined. The TLC plate for this 
extraction is shown in Fig.2.11. As mentioned in the previous extraction, ajoene’s 
position on the TLC plate was confirmed and it was predicted that it should be present 
in fractions 7-10 in this extraction (Fig.2.11). Therefore, fractions 7-9 and fraction 10 
were tested for ajoene using MS. Ajoene was detected from fractions 7 to 9. The Mass 
spectrum of fractions 7 - 9 is shown in Fig.2.12. The final weight of the yellow oil in 
fractions 7-9 was 0.0973g after evaporating the solvent. This extract will be termed 
“4GE” in the following chapters. 
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Figure 2.11.  The TLC plate of the fractions collected from flash chromatography 
for the fourth garlic extraction. Fractions 7-9 and fraction 10 were tested on MS. 7-9 
was ajoene positive based on the following MS data. 
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Figure 2.12.  Mass spectrum of fractions 7-9 of the fourth extraction. Ajoene was 
detected in both H
+
 (molar mass 227.1276) and Na
+
 (molar mass 257.0096) form. 
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Conclusion 
In the four independent extractions, we managed to extract ajoene from garlic 
in the first, third and fourth extraction. The identity of ajoene in the garlic extracts 
was confirmed by mass spectrometry (MS) and Nuclear magnetic resonance (NMR) 
spectroscopy. The NMR spectroscopy result suggested that the ajoene in the extracts 
was a mixture of E and Z isomers. The purity of ajoene in each garlic extract was 
reasonably high as shown in the MS and NMR results.  
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Appendix 
Appendix 2.1 
Acquisition Parameter of Mass spectrometry   
Source type ESI 
Ion polarity Positive 
Set nebulizer 1.0 Bar 
Focus Not active 
Set capillary 4000 V 
Set dry heater 200 
o
C
 
Scan begin 
Set end plate offset 
Set dry gas 
Scan End 
Set collision cell RF 
  50 m/z 
  -500 V 
  8.0 I/min 
  1000 m/z 
  1800.0 Vpp 
Set divert value   Waste 
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Chapter 3 - Antifungal activity of ajoene 
Introduction 
Garlic has been shown to have antifungal effects towards a variety of different 
species of fungi (Ledezma et al., 1996). Its antifungal effects are suggested to be due 
to the large number of active sulfur containing compounds that are found in garlic 
extract (Iciek et al., 2009). Of these, allicin, which is produced during the crushing of 
garlic cloves, is believed to be mostly responsible for the antimicrobial activity of 
garlic (Cavallito & Bailey, 1944). In later research, allcin is found to have antifungal 
activities against a broad spectrum of microorganisms both in vitro and in vivo. These 
species include Candida spp., Cryptococcus spp., Trichophyton spp. and Aspergillius 
spp (Aala et al., 2010; Gruhlke et al., 2010; Khodavandi et al., 2011; Shadkchan et al., 
2004; Yamada & Azuma, 1977). 
However, in terms of its use to tackle fungal infections, the pitfall of the active 
compound allicin is that it is very unstable at the normal human body temperature. 
This means that there is only a trace amount of allicin found in human blood at a 
temperature of 37
o
C several minutes after addition of allicin to the blood in 
volumetric flask (Freeman & Kodera, 1995). At room temperature, as mentioned in 
the previous chapter, allicin readily converts to ajoene when it is mixed with edible oil 
or alcohol (Block et al., 1986). The degradation product ajoene of allicin is more 
stable than allicin and the pharmacological activity of ajoene is therefore much more 
likely to be preserved (Ilić et al., 2011). Since its discovery, ajoene’s antifungal effects 
have been demonstrated on many fungal species. It has shown very strong antifungal 
activity on Aspergillus niger and Candida albicans (S. Yoshida et al., 1987). San-Blas 
et al. (1989) tested ajoene on the dimorphic fungus Paracoccidioides brasiliensis and 
found that it inhibited both the yeast and mycelial phase growth (San-Blas et al., 1989) 
and later in 1997 the same group suggested that the inhibition was probably due to 
inhibition of phosphatidylcholine synthesis and disruption of the fatty acid 
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composition of the fungal plasma membrane (San-Blas et al., 1997). Naganawa et al. 
(1996) found that ajoene had a microbicidal effect on yeast when the concentration of 
ajoene was increased to 30 μg/ml. Since the fungi were only killed effectively during 
cultivation, they suggested that the antifungal function of ajoene was effective on 
growing cells (Naganawa et al., 1996). More recently, clinical trials were carried out 
to test ajoene’s potential as an antifungal drug. The antifungal activity of ajoene and 
the antifungal drug 5-fluorouracil has been compared for the treatment of 
Cladophialophora carrionii chromoblastomycosis on patients. Chromoblastomycosis 
is a localized chronic fungal infection, usually causing papules on skin and 
subcutaneous tissues. Further development of this infection may cause the spreading 
of the fungus into blood or lymphatic vessels. The authors suggested that the cure rate 
was similar between the 5-fluorouracil and ajoene treatment but the ajoene treated 
group seemed to have a lower chance of relapse and skin damage (Pérez-Blanco et al., 
2003). Moreover, Ledezma et al. (2000) tested 1% ajoene in an inert hydrosoluble gel 
on soldiers with Tinea pedis and the efficacy of treatment was 100%. The efficacy of 
ajoene treatment was higher than the drug terbinafine, a synthetic allylamine 
antifungal drug mainly used for treating dermatophytosis  (Ledezma et al., 2000). 
The dimorphic fungus Candida albicans grows in both a yeast and a 
mycelial form, and it has significant contribution to oral and genital infections in 
humans (Gow & Gadd, 1995). The overgrowth and opportunistic infection of the 
fungus results in candidiasis which is often observed in immunocompromised 
individuals such as AIDS and cancer patients (Calderone & Clancy, 2012; Tylicki et 
al., 2012). When C. albicans is cultivated on agar plate at 37
o
C, it grows in yeast form, 
when cells are grown in a medium similar to physiological environment of a human 
host, they grow as "true" hyphae which are often at the site of invasion (Berman & 
Sudbery, 2002).  
The budding of yeast and polarized extension of hyphae are two distinct patterns 
of fungal growth, and the cytoskeleton is thought to play a crucial role both in 
budding and in polarized cell growth. In polarized cell growth of fungi, the 
microtubules and actin filaments are crucial for establishing and maintaining cell 
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polarity for the process of budding, fission or filamentous growth, but are also 
required for delivering the vesicles for polarized cell extension. That is, microtubules 
deliver the “cell end marker” proteins to cell pole, in order to organize the actin 
cytoskeleton for the transportation of vesicles to the cell end (Fischer et al., 2008).  
During mitosis of eukaryotic cells, microtubules and actin filaments are 
assembled specially in M phase of the cell cycle. After the chromosomes are 
replicated, the microtubules and accessory proteins are assembled to form bipolar 
mitotic spindles, these function to separate the chromosomes and allocate one copy to 
each daughter cell. Then the actin filaments and myosins form a contractile ring or 
cell plate that facilitates cell division (Alberts et al., 2002).   
As mentioned above, ajoene is able to inhibit the growth of both yeast and 
mycelial form of P. brasiliensis (San-Blas et al., 1989). The underlying mechanism is 
still unclear. The inhibition of yeast and mycelial growth by ajoene may or may not be 
achieved by same target. Achlya bisexualis is one of the Achlya species which 
normally cause aquatic animal diseases (Fuangsawat, Abking, & Lawhavinit, 2011). 
A.bisexualis and Neurospora crassa are model microorganisms frequently used for 
research into filamentous growths. In this chapter, the antifungal effects of ajoene 
were tested on the dimorphic fungus C. albicans and on filamentous cells of N. crassa 
and A. bisexualis, in order to investigate any inhibitory activity of ajoene on both 
yeast and mycelial form of growth. 
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Materials 
Strains of Candida albicans C57, Neurospora crassa and Achlya bisexualis were 
obtained from the collection of the University of Canterbury. Growth media PYG 
(components shown in Appendix 3.1) media was used for growth and maintenance of 
Neurospora crassa and Achlya bisexualis. PDB and PDA (potato dextrose broth and 
agar, components shown in Appendix 3.2) were used for growth and maintenance of 
Candida albicans C57. Human blood serum for germ tube formation was obtained 
from Christchurch Hospital, New Zealand. Ninety six well microplates for C. albicans 
incubation were from BD Falcon limited, New Zealand.  
 
Methods 
C. albicans treatment and cell division assessment 
A colony of C. albicans on fresh PDA plate was inoculated in 15 ml of PDB and 
the broth was incubated at 37 ºC for 24 hours. The cell number in the broth was 
determined with a haemocytometer after the incubation. Based on the cell counting, 
the original broth was diluted to 5x104 cells/ml and 200 µl of the diluted cell solution 
was added to each well of a 96 well microplate. 
1GE (ajoene from first garlic extraction) was diluted to 1mg/ml before its use in 
experiments. 1GE at the concentrations of 5, 10, 20, 40, 60 and 80 µg/ml were used to 
treat C. albicans and there were 5 replicates of cells in each concentration group. The 
volume of 1GE used for each group is listed in Appendix 3.3. 
The plate was incubated at 37 
o
C for 24 hours, and the cell density which was 
taken to represent the amount of cell division of C. albicans was monitored by the 
absorbance of solution in the wells at 530 nm. 
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C. albicans germ tube length comparison 
  A colony of C. albicans on a fresh PDA plate was added to 2 ml of human blood 
serum and mixed thoroughly. The serum was then divided into two equal parts and 
added into 2 sterile eppendorf tubes. 35 µl of 1mg/ml 1GE was added to one of the 
tubes so that the final concentration of ajoene in the serum was 35µg/ml. Both tubes 
were then incubated at 37 
o
C for 3 hours. After incubation, the serum in each of the 
tubes was observed under the microscope. Fifty germ tubes were measured for each 
group and the average results were averaged.  
 
A.bisexualis and N.crassa treatment and hyphae extension assessments 
 
Radial extension of the whole culture 
Growth media which contained 5, 10 or 20 µg/ml of 1GE was made by adding 
1GE to melting PYG media containing 2% agar and 2.5 ml of the media was poured 
into each of the 55mm x 15mm Petri dishes. The volumes of 1GE used in each group 
of plates are listed in appendix 3.4. Fresh cultures of A. bisexualis and N. crassa were 
inoculated with a cork borer on the center of plates. The N. crassa plates were 
incubated at 22 ºC for 24 hours and the A. bisexualis plates were incubated at 22 ºC 
for 48 hours. The diameters of colonies were measured after incubation. 
 
Individual hyphal extension 
Growth media was prepared by laying a piece of sterile cellophane over PYG 
agar. Fresh cultures of N. crassa and A. bisexualis were inoculated on the cellophane 
on the plate. The N. crassa plates were incubated at 22 ºC for 24 hours and the 
A.bisexualis plates were incubated at 22 ºC for 48 hours for further analysis.  
 After incubation, a perfusion slide was made by spotting nail polish on a glass 
slide and the filamentous cell culture on cellophane was cut and placed on the slide 
between the spots and immersed in liquid PYG medium. The culture was then 
covered with a coverslip and extension of an individual hypha was observed under 
microscope. Hyphal growth rate was measured by observed the growing distance of 
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individual hypha over a specified time. After the measurement, the medium on slide 
was then replaced by perfusion with PYG medium which contained 20 µg/ml of 1GE. 
The extension rate of the same hypha was measured again after the replacement of 
medium.  
 
Statistical analysis 
Data were statistically analyzed with Prism statistical software using Student’s 
t-test and P<0.05 was used to determine statistical significant. All data were presented 
as mean+SEM.  
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Results  
Results listed below were the average results of 3 independent experiments, and 
the detailed statistical data was shown in Appendix 3.5. 
 
Effect of ajoene on C. albicans cell division 
 The turbidity (Absorbance) in wells of the 96 well plate was used to indicate the 
cell number of C. albicans after incubation and hence the ability of the culture to 
divide. When C. albicans was incubated with ajoene, there was a significant decline 
in cell division with 5 µg/ml ajoene. The inhibitory effect of ajoene increased as the 
concentration of ajoene was increased. The MIC50 (Minimum inhibitory concentration 
for inhibiting 50% of the cell division) was estimated to be 15 µg/ml and MIC90 
(Minimum inhibitory concentration for inhibiting 90% of the cell division) was 
estimated to be 35 µg/ml. The comparisons of average absorbance between the groups 
are shown in Fig.3.1  
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Figure 3.1.  Relative absorbance of medium of C. albicans after incubation with or 
without ajoene. As the concentration of ajoene increased, the absorbance (turbidity) 
decreased in a dose dependent manner. The absorbance of the 5, 20, 40, 60, 80 µg/ml 
ajoene treated wells were significantly lower than the control wells (P < 0.05, t test).  
Data was normalized to the absorbance of the control well, thus the data on y axis is 
the percentage calculated by dividing the average absorbance of each group with the 
average absorbance of control group. The MIC50 was estimated to be 15 µg/ml and 
MIC90 was estimated to be 35 µg/ml. 
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Effect of ajoene on C. albicans germ tube length 
Three individual experiments were completed and 50 germ tubes in each group 
were measured in each experiment. Due to the limited amount of 1GE, only one 
concentration 35 µg/ml, which was the MIC90 of ajoene on C.albicans cell division, 
was used in treating C. albicans germ tubes. After 3 hours of incubation in serum with 
or without ajoene, germ tubes of C. albicans formed and the average length of the 
germ tubes in 35 µg/ml ajoene treated groups were more than 50% shorter than these 
of the control groups. The relative lengths of germ tubes in control and ajoene treated 
groups are shown in Fig.3.2. 
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Figure 3.2.  Comparison of the length of C. albicans germ tubes in serum with or 
without ajoene. Again data was normalized to the length of the control groups. The 
germ tubes formed in serum contained 35 µg/ml ajoene were significantly shorter 
than the ones in normal serum (P<0.05, t test). 
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Effect of ajoene on radial extension of N. crassa mycelia 
 When N. crassa was inoculated on the PYG plates with or without ajoene, radial 
extension of the fungal mycelia became visible in 24 hours in all groups. The size of 
N. crassa mycelia was obtained by taking the average diameter from the diameters at 
3 different angles. Average diameters of the N. crassa mycelia treated with ajoene at a 
5 µg/ml or higher concentrations were significantly lower than that of the control 
groups. The diameter of 5 µg/ml ajoene treated N. crassa mycelia was about 46% 
shorter than that of the control groups. Data and comparisons are shown in Fig.3.3. 
The images of culture plates after incubation are shown below in Fig.3.4. 
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Figure 3.3.  The average colony diameter of N. crassa after incubation with or 
without ajoene. As the concentration of ajoene was increased, the diameters of the 
fungal colony decreased in a dose dependent manner. The diameters of the ajoene 
treated mycelia were all significantly smaller than the control ones (P < 0.05, t test).  
Again data was normalized to the diameter of the control colony, thus the figures on y 
axis are the percentages calculated by dividing the average diameter of each group 
with the average diameter of control group.  
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Figure 3.4.  Images of N. crassa culture plates taken after 24 hours of incubation. 
The photos clearly indicate that the colony size decreased significantly due to addition 
of ajoene in growth media. Red circles indicate the edges of the mycelia. 
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Effect of ajoene on hyphal extension of N. crassa 
N. crassa hyphae on cellophane on a glass slide were allowed to grow for 30 to 
60 minutes. The extension rate was calculated by measuring the distance of an 
individual hypha’s extension in a certain time. The same hypha was measured before 
and after the addition of ajoene to the PYG medium. The average extension rates 
(µm/min) were obtained from 3 independent experiments.  
 The average rate of N. crassa hyphal extension in PYG medium containing 20 
µg/ml ajoene was 92.46% slower than that in normal PYG medium. The comparison 
of relative extension rate between control and ajoene treated groups is shown in 
Fig.3.5.  
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Figure 3.5.  Growth rate of individual N. crassa hypha in PYG broth and in PYG 
broth which contained 20 µg/ml ajoene. The results were normalized by dividing the 
result of ajoene treated group with the control group. The figure shows that hypha 
grew significantly slower in ajoene treated medium than in normal medium (P<0.05, t 
test). 
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Effect of ajoene on radial extension of A. bisexualis mycelia 
When A. bisexualis was inoculated on the PYG plates with or without ajoene, 
radial extension of the mycelia became visible in 48 hours in all groups. Again size of 
A. bisexualis colony was obtained by taking the average diameter from the diameters 
of 3 different angles. Average diameters of the A. bisexualis mycelia treated with 
ajoene at a 5 µg/ml or higher concentrations were significantly lower than that of the 
control groups. However, the inhibitory effect of ajoene on A. bisexualis was less than 
on N. crassa. The average mycelia diameter in 5 µg/ml ajoene treated groups was 
about 13.7% shorter than the control groups. Data and comparisons are shown in 
Fig.3.6. The images of culture plates after incubation are shown below in Fig.3.7. 
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Figure 3.6.  Average relative colony diameter of A. bisexualis after incubation with 
or without ajoene. The diameters of A. bisexualis colony decreased in a dose 
dependent manner. Results in the ajoene treated mycelia were all significantly lower 
than control wells (P < 0.05, t test). Again, data was normalized to the diameter of the 
control colony. 
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Figure 3.7.  Images of A. bisexualis culture plates taken after 48 hours of incubation. 
The photos clearly indicate that the colony size decreased significantly due to addition 
of ajoene in growth media. Red circles indicate the edges of mycelia. 
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Effect of ajoene on hyphal extension of A. bisexualis 
As for N. crassa, the hyphal extension rate of A. bisexualis was calculated by 
measuring the distance an individual hypha extended in a certain time. The same 
hypha was measured before and after the addition of ajoene to the PYG medium. The 
average extension rates (µm/min) were obtained from 3 independent experiments.  
 The average rate of A. bisexualis hyphal extension in PYG medium contained 20 
µg/ml ajoene was significantly slower than that in normal PYG medium. Again, the 
effect of ajoene on A. bisexualis individual hyphal extension was milder than that on 
N. crassa. The relative extension rates of A. bisexualis are shown in Fig.3.8.  
 
 
G ro u p
G
R
a
jo
e
n
e
/G
R
c
o
n
tr
o
l(
%
)
c o
n
tr
o
l
2 0
 μ
g
/m
l a
jo
e n
e
0
5 0
1 0 0
1 5 0
 *
 
Figure 3.8.  Individual A. bisexualis hypha growth rate in PYG broth and in PYG 
broth which contained 20 µg/ml ajoene. Again results were normalized by dividing 
the result of ajoene treated group with the control group. The figure shows that hypha 
grew significantly slower in ajoene treated medium than in normal medium (P<0.05, t 
test). 
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Discussion  
The results above indicated that the yeast form of C. albicans showed significant 
decline in a cell number, even at low concentration of ajoene (5µg/ml). The MIC50 
was estimated to be 15µg/ml and MIC90 was estimated to be 35µg/ml. The MIC90 
value is higher than the MIC95 in previous study of Yoshida et al. which was 7.6 
µg/ml (S. Yoshida et al., 1987), This is likely to be because of the lower purity of 
ajoene and different methods used in this project.  
When C. albicans was incubated in serum, germ tube formed after the incubation. 
Germ tubes are the slender hyphae which emerge from a germinating spore (Carlile, 
1995). The concentration of ajoene used in the germ tube tests was that which gave 
the MIC90 for division of the yeast form of C. albicans. The germ tube length of C. 
albicans had more than a 50% decline in the 35µg/ml ajoene treated groups.  
The yeast form of C. albicans is thought to be important for dissemination 
through the blood stream, and the ability of switching from yeast form to hyphae form 
was suggested to be associated with the virulence of C. albicans (Berman & Sudbery, 
2002; Gow, Brown, & Odds, 2002). A cph1/cph1 efg1/efg1 double mutant C. albicans, 
which failed to switch from yeast to filamentous forms, was unable to cause damage 
to microphages (Lo et al., 1997). The germ tube, the initial stage of the formation of 
C.albicans hyphae, was considered to be one of the important virulence factors and 
essential for tissue adhesion (Wellmer & Bernhardt, 1997). The length of germ tube 
has been found to be correlated with tissue invasion and tissue damage (Kretschmar et 
al., 1999). In the present study, ajoene was able to inhibit both yeast division and 
germ tube extension. While ajoene has been tested on C. albicans previously (Carrero, 
Romero, & Apitz-Castro, 2009; S. Yoshida et al., 1987), to the best of my knowledge 
this is the first time that ajoene has shown inhibitory effects on both yeast and germ 
tubes of C. albicans. 
The mechanism of the inhibitory effect of ajoene on C. albicans cell division is 
still under debate. San-Blas‘s group reported  that ajoene was able to reduce the 
phosphatidylcholine level and disturb the fatty acids composition in plasma 
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membrane of the yeast form of P. brasiliensis, and they suggested that the antifungal 
effects of ajoene might associated with the disturbance of fungal membrane (San-Blas 
et al., 1997).  
Cysteine residues of proteins were also suggested to be one of the targets of 
ajoene since addition of cysteine to the ajoene containing fungal growth medium 
caused a decline in ajoene concentration, and the inhibitory effect of ajoene on 
P.brasiliensis was reduced by addition of cysteine (Naganawa et al., 1996). Garlic 
derivatives that include ajoene were suggested to achieve their biological activity by 
reacting with the cysteine residues in proteins because the sulfhydryl group on 
cysteine can easily be modified by disulfide structures (Jacob et al., 2012). When 
ajoene was tested on cancer cells, the mitosis of the cells were blocked and apoptosis 
was induced by ajoene, which was suggested to be due to the oxidation of cysteine, 
inhibition of microtubule assembly and ROS (reactive oxygen species) induced by the 
disulfide group of ajoene (Dirsch et al., 1998; Jacob et al., 2012; Kaschula et al., 2012; 
Li et al., 2002). C. albicans cell division, which is a mitosis process, was possibly 
blocked by ajoene via the modification of cysteines on tubulin and blockage of 
microtubule assembly.  
When C. albicans switches to the hyphal growth form and generates germ tubes, 
the role of microtubules was also suggested to be important for both germ tube 
formation and growth. Barton and Gull (1998) stained both the yeast form and germ 
tubes of C. albicans using immunofluorescence and they found that mitotic spindles 
in germ tubes were much longer than the ones in yeast form of C. albicans. They 
suggested that microtubules were responsible for positioning the nuclei in the center 
of the germ tubes (Barton & Gull, 1988). Blockage of microtubule assembly by 
ajoene could also result in the reduction of germ tube length in C. albicans. 
 Radial extension of the ascomycete N. crassa and the oomycete A. bisexualis 
mycelia on agar plates were both inhibited by ajoene. The diameters of the N. crassa 
colony on plates which contained 5µg/ml ajoene were almost 50% smaller than that of 
control plates. A. bisexualis was less sensitive to ajoene than N. crassa but still had a 
significant decline in radial extension. When individual hyphal extension was 
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observed on cellophane under the microscope, the pattern agreed with the on plate 
pattern. The individual hyphal extension rate of N. crassa was reduced by 20µg/ml 
ajoene. Again, the response of A. bisexualis hypha extension rate to ajoene treatment 
was less than that with N. crassa.  
 As mentioned above, the antifungal activity of ajoene was possibly due to the 
disturbance of cell membrane or inhibition of microtubules. Composition of cell 
membrane presents a wide deviation among microorganisms. Tylicki and co-workers 
compared the fatty acids profiles of Malassezia pachydermatis, Candida albicans and 
Saccharomyces cerevisiae and the fatty acid content varied among the species, which 
may therefore influence the responses of the microorganisms to drug (Tylicki et al., 
2012).  Mu’s group compared β-tubulin encoding cDNAs between the ascomycete 
Pestalotiopsis microspora and the oomycetes Pythium ultimum, and the responses of 
the two microorganisms to taxol. The author suggested that a sequence difference in 
β-tubulin resulted in the distinct pattern of responding to taxol (Mu, Bollon, & Sidhu, 
1999).  
A. bisexualis belongs to oomycetes, a group that are phylogenetically distant from 
the kingdom Fungi (Förster, Coffey, Elwood, & Sogin, 1990). Oomycetes were 
considered to belong to Chromalveolata along with algae, and are believed to be some 
of the most distantly related eukaryotes to fungi (Richards, Dacks, Jenkinson, 
Thornton, & Talbot, 2006). The distant phylogenetic relationship between 
A.bisexualis and N. crassa may result in the difference in composition of cell 
membrane or in tubulin sequence. Moreover, it was suggested that hyphae growth rate 
correlated with the microtubule dynamics. N. crassa had one of the fastest 
microtubule polymerization rate and growth rate in filamentous fungi (Uchida, 
Mouriño-Pérez, Freitag, Bartnicki-García, & Roberson, 2008), which may also played 
a part in the greater response to the microtubule inhibitor ajoene.  
.  Due to time constrain and availability of ajoene amount, the concentrations of 
ajoene and the time in the above experiments were limited. For example, only 35 
µg/ml was used in germ tube experiments, and the hyphae radial extension was done 
only on small plates thus the growth of N. crassa and A. bisexualis were not able to be 
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investigated further than 24 hours. In a future study, more concentrations of ajoene 
could be tested on these organisms and the effects of ajoene on the cytoskeleton could 
be assessed in depth details by suitable biochemical techniques.  
  
 
Conclusion 
C. albicans cell division was inhibited by ajoene at 5 µg/ml or higher concentrations. 
The length of ajoene treated C. albicans germ tubes was significantly shorter than 
non-treated ones. Ajoene was also able to inhibit the radial extension and individual 
hyphal extension of N. crassa and A. bisexualis but the response of A. bisexualis to 
ajoene was less marked than N. crassa. The effect of ajoene may be due to its effect 
on membrane lipids or the microtubule cytoskeleton. 
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Appendix 
Appendix 3.1.  Ingredients of PYG media 
Components Concentration 
Glucose (Merck) 3 g/L 
Bacterial peptone (Sigma) 1.25 g/L 
Yeast extract (Sigma) 1.25 g/L 
20 g/L Agar (Sigma ltd) 
 
 
 
Appendix 3.2.  Ingredients of PDA media and PDB broth 
Components Concentration 
BD Difco™ potato dextrose broth 24 g/L  
Agar  20 g/L for PDA or 0 for PDB 
 
 
 
Appendix 3.3.  C.albicans was treated with various concentrations of ajoene. 
Volume of 1GE and 5x10
4 
cells/ml cell solution added for each concentration group is 
listed below. 
 Control 5μg/ml 10μg/ml 20μg/ml 40μg/ml 60μg/ml 80μg/ml 
1mg/ml 1GE   -  -  - 4 μl 8μl 12 μl 16 μl 
500μg/ml 
1GE 
  - 2μl 4μl  -  -  -  - 
Solution/well 200 μl 200 μl 200 μl 200 μl 200 μl 200 μl 200 μl 
 
 
 
Appendix 3.4.  A. bisexualis and N. crassa were treated with various concentrations 
of ajoene. Volumes of 1GE and media for making up PYG plates contained various 
concentrations of ajoene are listed below. 
 
 
 
 
 Control 5μg/ml 10μg/ml 20μg/ml 
1mg/ml 1GE 0 12.5 μl 25 μl 50 μl 
Media/PYG 
plate 
2.5 ml 2.5 ml 2.5 ml 2.5 ml 
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Appendix 3.5. 
Unpaired t test of C.albicans control wells vs 5μg/ml ajoene treated wells 
P value 0.0345 
P value summary * 
Significantly different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=3.151 df=4 
How big is the difference?  
Mean ± SEM of column A 100.0 ± 0.0 N=3 
Mean ± SEM of column B 97.33 ± 0.8474 N=3 
Difference between means -2.670 ± 0.8474 
95% confidence interval -5.023 to -0.3173 
R square 0.7128 
 
 
 
Unpaired t test of C.albicans control wells vs 10 μg/ml ajoene treated wells 
P 
value 
                                                               
      0.1281 
P value summary ns 
Significantly different? (P < 0.05) No 
One- or two-tailed P value? Two-tailed 
t, df t=1.914 df=4 
How big is the difference?  
Mean ± SEM of column A 100.0 ± 0.0 N=3 
Mean ± SEM of 
column C 
                                          84.73 ± 
7.979 N=3 
Difference between means -15.27 ± 7.979 
95% confidence interval -37.43 to 6.881 
R square 0.4781 
 
 
 
Unpaired t test of C.albicans control wells vs 20 μg/ml ajoene treated wells 
P 
value 
                                                               
    < 0.0001 
P value summary **** 
Significantly different? (P < 0.05) Yes 
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One- or two-tailed P value? Two-tailed 
t, df t=28.47 df=4 
How big is the difference?  
Mean ± SEM of column A 100.0 ± 0.0 N=3 
Mean ± SEM of column D 18.93 ± 2.848 N=3 
Difference between means -81.07 ± 2.848 
95% confidence interval -88.98 to -73.17 
R square 0.9951 
 
 
Unpaired t test of C.albicans germ tube length compared between control and 
35µg/ml ajoene treated group 
P value < 0.0001 
P value summary **** 
Significantly different? (P < 
0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=16.52 df=4 
How big is the difference? 
 Mean ± SEM of column A 100.0 ± 0.0 N=3
Mean ± SEM of column B 46.76 ± 3.224 N=3 
Difference between means -53.24 ± 3.224 
95% confidence interval -62.19 to -44.29 
R square 0.9855 
 
 
 
Unpaired t test of N. crassa colony diameter compared between control and 
5µg/ml ajoene treated groups 
P value 0.0006 
P value summary *** 
Significantly different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=9.691 df=4 
How big is the difference?  
Mean ± SEM of column A 100.0 ± 0.0 N=3 
Mean ± SEM of column B 53.76 ± 4.771 N=3 
Difference between means -46.24 ± 4.771 
95% confidence interval -59.48 to -32.99 
R square 0.9592 
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Unpaired t test of A. bisexualis colony diameter compared between control and 
5µg/ml ajoene treated groups 
P value 0.0071 
P value summary ** 
Significantly different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=5.066 df=4 
How big is the difference?  
Mean ± SEM of column A 100.0 ± 0.0 N=3 
Mean ± SEM of column B 86.49 ± 2.667 N=3 
Difference between means -13.51 ± 2.667 
95% confidence interval -20.91 to -6.106 
R square 0.8652 
 
 
 
Unpaired t test of A. bisexualis on slide hypha growth rate compared between 
control and 20µg/ml ajoene treated group 
P value 0.0021 
P value summary ** 
Significantly different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=7.082 df=4 
How big is the difference?  
Mean ± SEM of column D 100.0 ± 0.0 N=3 
Mean ± SEM of column E 36.51 ± 8.964 N=3 
Difference between means -63.49 ± 8.964 
95% confidence interval -88.38 to -38.60 
R square 0.9261 
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Chapter 4 – Antitumor activity of ajoene 
Introduction 
Endometrial cancer is the most common gynecologic cancer (Roque et al., 2013), 
and it accounts for almost 5% of female cancers in the world with a high incidence 
rate in western countries (Mileshkin & Jamil, 2012). In the U.S, it is estimated that 
there are 47,130 new cases and 8010 deaths annually (Fader, Santin, & Gehrig, 2013). 
Endometrial tumors are solid tumors, and according to the clinical behavior and 
histopathology, endometrial cancer can be divided into several stages (Chitcholtan, 
Sykes, & Evans, 2012; Roque et al., 2013). 80% of women with endometrial cancer 
are diagnosed at an early stage with low grade tumors, and the 5 year survival rate of 
this type is higher than 80% (Fader et al., 2013; Purdie & Green, 2001; Roque et al., 
2013). Advanced stage endometrial cancers, especially uterine serous carcinoma, are 
in contrast aggressive and have very poor prognosis (Fader et al., 2013; Roque et al., 
2013).  
The treatment for early stage endometrial cancer includes surgery, radiotherapy or 
a combination of these two. For advanced stage cancers, chemotheraphy and 
hormonal therapy plays an important role in management of the disease. Cytotoxic 
drugs such as paclitaxel, doxorubicin and cisplatin are heavily used to treat the 
advanced endometrial cancer as a single agent or in combinations (Markman, 2007; 
Steer & Harper, 2001).  
Paclitaxel was originally extracted from leaves of Camptotheca acuminata Decne 
in 1966. It binds to polymerized tubulin, promotes and stablizes polymerized 
microtubules and thus arrests cells in mitosis (Cragg & Newman, 2004). Today, 
paclitaxel is widely used as a chemotherapeutic agent and is used as a first-line 
treatment for all stages of many cancers and is very commonly used in advanced and 
metastatic endometrial cancer treatment (Mileshkin & Jamil, 2012; Vilos et al., 2013). 
However, the toxicity of paclitaxel is quite excessive. Adverse side effects include 
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peripheral neuropathy, myelosuppression, arthralgias, myalgias and skin problems. 
Therefore, clinical doses of palcitaxel are limited to achieve good responses due to the 
severity of adverse effects (Cella, Peterman, Hudgens, Webster, & Socinski, 2003). 
 Novel targeted drugs, which target the dysfunctional signaling pathways that may 
underlie malignancy have attracted increasing attention, and have the potentiality to 
be used as second or third line treatments for endometrial cancers, as beneficial results 
have been noticed by combining targeted drugs with cytotoxic drugs in clinical trials 
(Cortes & Roché, 2012; Dedes, Wetterskog, Ashworth, Kaye, & Reis-filho, 2011; 
Dizon, 2010). In endometrial cancer, the most common mutations are on the cell cycle 
regulator gene p53 or on phosphatase and tensin homologue (PTEN), which regulates 
the PI3K/AKT/mTOR pathway. Dysfunction of p53 protein results in uncontroled cell 
progression and dysfunctioning of PTEN results in enhanced cell proliferation 
(Albitar, Carter, Davies, & Leslie, 2007) (Fig.4.1). Therefore, a drug that can target on 
molecules associating with the PI3K/AKT/mTOR pathway or its upstream pathway 
would have a potential in the clinical appication. For example, gefitinib and canertinib 
are targeted inhibitors for the upstream signalling molecules EGFR/HER2, and 
everolimus is a mTOR (mammalian target of rapamycin) inhibitor. These targeted 
drugs exhibit anti-tumour effects on cell proliferation through the PI3K/AKT/mTOR 
pathway. In addition to the PI3K/AKT/mTOR pathway, the activation of vascular 
endothelial growth factor (VEGF) via its receptors (VEGFRs) is also crucial for 
tumour survial. Blocking this conconical VEGF-VEGFRs axis is proven to be good 
target for cancer treatments. The targeted agent such as sorafenib is shown to have 
efficacy in tumours that have VEGF-VEGFRs dependent survival (Dedes et al., 
2011).  
Researchers have also made efforts to search for treatment that produce less 
adverse effects on patients. The rationale of the use of natural food products as 
adjuvant therapy in cancer is gaining popularity. Many bioactive food compounds 
have been isolated, and this includes an active comound from garlic. The garlic 
derivative ajoene (Scheme 1) has been found to be able to inhibit tumor progression in 
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vitro and in vivo. Its antitumor effects have been tested on various cell lines, such as 
HL-60 and PtK2 (Dirsch et al., 1998; Li et al., 2002), and it is also able to reduce the 
growth of primary metastasis of B16/BL6 melanoma tumor in mice (Taylor et al., 
2006). Furthermore, patients with basal cell carcinoma were treated with ajoene by 
applying 0.4% ajoene cream on a tumor site, and 17/21 had a reduction in the size of 
tumor. To reveal the underlying mechanism of ajoene’s effects, the authors then tested 
ajoene on basal cell cancer cell lines, cancer cell death (apoptosis) was detected by 
flow cytomety analysis (Tilli et al., 2003). Induction of apoptosis by ajoene was also 
suggested by other groups. Dirsch’s group reported that when HL-60 cells were 
treated with ajoene, reactive oxgen species (ROS) were generated and nuclear factor 
kB (NF-kB) was activated (Dirsch et al., 1998). However, there is also evidence of 
disruption of the cell cycle by ajoene. Xu’s group reported that the amount of 
cytosolic proteasome was increased when HL-60 cells were treated with ajoene, and 
cells were arrested in the G2/M phase and proteasome activity was inhibited by 
ajoene (B. Xu, Monsarrat, Gairin, & Girbal-Neuhauser, 2004). Li’s group suggested 
that ajoene inhibited tumor cell growth by inhibition of microtubule assembly and the 
subsequent interruption of the cell cycle (Li et al., 2002). Structure-activity studies 
have also been performed and the anti-proliferative effect of ajoene is suggested to be 
due to the vinyl disulfide site of ajoene (Scheme 4.1). The vinyl disulfide structure is 
believed to be responsible for the reaction with microtubule cysteine residues and 
anti-polymerization of microtubules, caspase 3 and ROS activation (Erkoc et al., 2003; 
Jacob et al., 2012; Kaschula et al., 2012).  
In this study, for the first time, ajoene combined with paclitaxel and the selected 
targeted drugs will be tested on an endometrial adenocarcinoma cell line to investigate 
the antitumor effects of ajoene and in combination with other drugs to determine if 
there is any additive/synergistic effects among these compounds. A 3D spheroid 
model of endometrial cancer cells grown on non-adherent surface, will be employed 
for cell culture and treatment. The traditional method of testing drugs on cancer cell in 
vitro is using a 2D cell monolayer. Cells are grown on an adherent surface and drugs 
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are directly added to the cell monolayer. However this cell model may not reliably 
mimic the in vivo cell growth due to the lack of tissue-specific functions, 
morphological organization and extra- cellular matrix proteins (ECM) which are 
crucial for differentiation, normal growth, and maintenance of homoeostasis of cells 
(Chitcholtan et al., 2013). Therefore, effects of drugs received on a 2D monolayer cell 
culture may differ significantly from the effects in vivo. By contrast, the 3D spheroid 
model reflects more tumourigenic characteristics of cells and signaling in the 
microenvironment of spheroids is more likely to be related to that of a real tumor. For 
example, in colorectal cell lines, gene expression of EGFR and the impact of 
inhibition of EGFR are significantly different in lrECM 3D spheroid culture as 
compared to 2D cultures (Luca et al., 2013). Cell proliferation, differentiation and 
EGFR activation is also altered in 3D cell culture when endometrial cancer cells are 
cultured on ECM (Chitcholtan et al., 2013). The pattern in which pancreatic 
carcinoma spheroids respond to drugs differs significantly from 2D culture due to the 
matrix structure and their distinct physiological properties (Longati et al., 2013). Thus, 
the advantages of using 3D spheroid cultures have driven us to study the antitumor 
properties of ajoene and synergistic effects between drugs with this model.  
Antitumor activity and synergistic effects of paclitaxel and target drugs were 
initially screened on endometrial cell line Ishikawa cell spheroids. In the first 
screening experiments, spheroids were treated with paclitaxel, sorafinib, gefitinib, 
canertinib and everolimus and the drug effects were screened by measuring the 
growth activity of spheroids. Growth activity, metabolic activity and morphology of 
spheroids were further investigated in the second round after treatment with paclitaxel 
and everolimus. These experiments also served as precusor experiments for 
understanding the drug response patterns of Ishikawa 3D spheroids, and provided 
information for the later ajoene experiments. To analyze the effects of ajoene and its 
combination with cancer drugs on Ishikawa cells, growth activity, metabolic activity, 
morphology, cytoskeletons, cell proliferation and apoptotic activity of Ishikawa cells 
were analyzed after treatment with the drugs.  
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Figure 4.1.  Possible targeted pathways for the treatment of endometrial cancer. 
Current drugs under clinical investigation for the treatment of endometrial cancer and 
their target molecules in the PI3K/AKT/mTOR and VEGF signaling pathways are 
displayed. Proteins, ligands and tyrosine kinase domains positively regulating the 
pathways are displayed in green while proteins with a negative regulatory role are 
displayed in red. Arrows indicate the activation of a molecule or a process while blunt 
headed arrows indicate inhibition of a protein or process. The dashed arrow shows the 
positive feedback from mTORC2 on AKT resulting from the inhibition of mTORC1 
alone. Asterisks indicate dual-targeting drugs. Abbreviation: FKBP12, FK506-binding 
protein 12;  mTOR, mammalian target of rapamycin; mTORC1, mammalian target 
of rapamycin complex 1; mTORC2, mammalian target of rapamycin complex 2; PDK, 
phosphoinositide-dependent kinase; PI3K, phosphatidylinositol 2 kinase; PIP2, 
phosphatidylinositol 4,5-bisphosphate; PIP3, phosphatidylinositol 
(3,4,5)-trisphosphate; PTEN, phosphatase and tensin homologue deleted on 
chromosome 10. Fig. is reproduced from Dedes et al, 2011 (Dedes et al., 2011).  
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Scheme 4.1. Skeletal structure of ajoene (4,5,9-thrithiadodeca-1,6,11-triene 9-oxide, 
C9H14OS3). The disulfide group (1) was suggested to be reponsible for ajoene’s 
activity and the double bond (2) is thought to enhance the activity of the disfulfide. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 1 
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Materials and Methods 
Cell line and growth medium 
The endometrial cancer cell line, Ishikawa (grade 1 with PTEN and p53 
mutations) was gifted by Dr Masato Nishida, Kasumigaura National Hospital, 
Tsuchiura-shi, Ibaraki-ken, Japan. 
Cells were maintained and grown in DMEM-F12 medium (Catalogue number 
12500-096. Invitrogen, New Zealand) supplemented with 10% FBS, 500 units/ml of 
penicillin/streptomycin and 1mM glutamax. 
 
Drugs 
Drugs and their characteristics are listed in Table 4.1. 
 
Table 4.1.  Anticancer drugs used in this study. 
Drug Characteristics of drug Purchased from 
Paclitaxel Cytotoxic, microtubule inhibitor Sigma -Aldrich LTD, New Zealand 
Everolimus mTOR inhibitor LC laboratories, MA, USA 
Sorafenib VEGFR inhibitor LC laboratories, MA, USA 
Gefitinib EGFR inhibitor LC laboratories, MA, USA 
Canertinib EGFR/HER-2 inhibitor LC laboratories, MA, USA 
Ajoene Inhibit microtubule and induce 
apoptosis 
Extracted from garlic (1GE,3GE and 4GE) 
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Growth and treatment of Ishikawa cells 
Coating plates and culturing Ishikawa cells and spheroids 
Sterile low melting point agar (Roche, New Zealand) was mixed with nanopure 
water and autoclaved. Prior to using, agar was completely melted and 400 µl of the 
melted warm agar was added to each well of a 24 well plates (BD Falcon, New 
Zealand). The agar in each well was allowed to cool and polymerize and the plates 
were kept at 4
o
C prior to further use. 
   Endometrial cancer cell line, Ishikawa cell line, was cultured in a cell culture 
flask and was used after it reached 80% confluent. Firstly, the growth medium in a 
cultural flask was discarded and 10 ml of 1xPBS (components are shown in Appendix 
4.1) was added in order to wash cell media. After discarding the PBS, 5 ml of 
1xtrypsin- EDTA (Invitrogen, New Zealand) was added and the flask was incubated at 
37
oC in a humidified 5% CO2 atmosphere for 10-15 minutes until the cell monolayer 
was detached from the flask. 
 The cell suspension was then transferred to a sterile 15 ml tube, and 7 ml of 
1xPBS was added and mixed. The tube was then centrifuged at 1500 rpm for 5 min 
and the supernatant was discarded. 3 ml of pre-warmed growth medium was added to 
the cell pallet and mixed thoroughly with a pipette, and then 7 ml medium was added 
and mixed again so the total volume was 10 ml.  
 The cell concentration was then determined with a haemocytometer, and 
calculated volumes of the original cell solution was added to each well of the coated 
24 well plates which contained 1 ml of growth medium to achieve 2x10
4
 cells/well. 1 
ml of the cell solution was also added to the cultural flask which contained 6 ml of 
growth medium to prepare a new flask. The flask and plates were incubated at 37
o
C in 
a humidified 5% CO2 atmosphere and the flask was subcultured again once it reached 
80% confluent.  
 The cells growing on coated plates formed spheroids and the spheroids were 
allowed to grow for 6 days before treatment. The medium was replaced every two 
days.  
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Treatment with anticancer drugs 
 Spheroids were treated with either a single drug or combination of drugs. In 
combination of drugs, paclitaxel was combined with each one of targeted drugs to 
make up a toxic + non-toxic combination. In addition to being combined with 
paclitaxel, ajoene was also combined with everolimus to test efficacy. The drug 
combinations are listed in Table 4.2. 
Table 4.2.  Drug combination groups for treating Ishikawa spheroids 
Drug combination to reveal synergy 
(“toxic”+“nontoxic”) 
Concentrations 
Paclitaxel + Ajoene  Paclitaxel 100 nM or 50 nM with 5 and 10 
µg/ml of ajoene 
Paclitaxel + Sorafenib Paclitaxel 100 nM with 2 µM sorafinib 
Paclitaxel + Everolimus Paclitaxel 100 nM or 50 nM with 2 µM 
Everolimus 
Paclitaxel + Gefitinib Paclitaxel 100 nM with 2 µM Gefitinib 
Paclitaxel + Canertinib Paclitaxel 100 nM with 2 µM Canertinib 
Everolimus +ajoene 2 µM or 1µM Everolimus with 10 µg/ml 
ajoene 
 
 When spheroids were treated with single drug listed in Table 4.1 and drugs were 
replaced every two days. Then, the spheroids were allowed to have 2 days off from 
drugs, and then the spheroids were incubated with or without the same drug for the 
following 4 days. In combination treatments, paclitaxel or everolimus was added to 
the spheroids for the first 2-4 days and one of the other drugs was added to the 
spheroids for four days after the rest period. Fig.4.2 shows the method of drug 
treatment. The detailed treatment duration and doses will be explained further in the 
results section. On the 17
th
 day, spheroids were analyzed with various assays and 
images of spheroids were taken with a stereomicroscope. 
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Figure 4.2.  Method of drug administration on 3D spheroids. Drugs were added to 
the cells on Day 7 after the spheroids formed. 2 days drug free interval allowed the 
model to mimic the recovery period in clinical trials. Various analyses were carried 
out on Day 17. 
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Growth activity experiments (Crystal violet assay)  
  The crystal violet assay was employed to analyze the relative growth activity of 
Ishikawa spheroids. 
Spheroid from each well was added to a microtube and the growth medium was 
removed with a pipette. 700 µl of 1xPBS and 300 µl of 10xtrypsin-EDTA was added 
to each tube and mixed. The tubes were then incubated at 37
o
C for 30 minutes and 
centrifuged at 1500 rpm for 5 minutes after incubation. The supernatant was discarded 
and 50 µl of crystal violet (Sigma-Aldrich LTD, New Zealand) was added to each 
tube and the tubes were left at room temperature for 10 minutes. Then 1 ml of 
distilled water was added to each tube and mixed well to wash off any unbound 
crystal violet. The tubes were then centrifuged again at 1500 rpm for 5 minutes. The 
water washing step was repeated 3 times. After washing, 600 µl of 2% SDS 
(Sigma-Aldrich LTD, New Zealand) was added to the tubes and the tubes were mixed 
using a vortex. 200 µl of the solution from each tube was added to each well of 96 
well plates and the plates were read at 570 nm for absorbance.  
 
 
Metabolic experiments (Alamar Blue assay) 
Spheroid with 0.5 ml of medium from each well was added to a sterile 4 ml tube. 
50 µl of AlamarBlue (Invitrogen, New Zealand) was added to each tube and gently 
mixed. The tubes were then incubated at 37
o
C in a humidified 5% CO2 atmosphere for 
24 hours and the absorbance of each tube was read at 570 nm and 600 nm. Metabolic 
activity was calculated by deducting the 600 nm absorbance from the 570 nm 
absorbance.  
 
 
Immunoblotting analysis 
Cell proliferation and apoptotic activities were analyzed by Western blotting 
experiments. The proliferation markers PCNA, Akt, p-Akt, cell cycle marker 
cyclin-D2 and apoptotic markers caspase-3 and PARP were immunoblotted.  
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Components of the solutions used in Western blot experiments are shown in 
Appendix 4.2. The antibodies used are listed in Appendix 4.3.   
SDS -PAGE Sample preparation 
Spheroids from each group were added to a microtube on ice and 200 µl of RIPA 
lysis buffer was added to each tube (the volume was adjusted depending on the size of 
spheroids). The lysate was then kept on ice for 20 minutes. 20 µl of 5x loading sample 
buffer was added to the lysate. The lysates were mixed thoroughly with the loading 
sample buffer and were heated at 100
o
C for 10 minutes and then kept on ice until 
cooled down. Before loading the gels, lysates were spun at 12000 rpm for 7 minutes 
and kept on ice. 
 
Gel preparation  
After the gel station was assembled, 4 ml of 10% SDS gel solution (12% was 
used for caspase-3 detection) was added to the gel holder and the holder was topped 
up with milli Q water. The station was then incubated at 37
o
C for 1 hour. The stacking 
gel was prepared by adding the stacking gel solution on top of the solid SDS gel to the 
top of the glass holder after the water was discarded. Combs were inserted and the 
station was left in room temperature for 30 minutes. After the incubation, combs were 
removed and the gel holders were removed from the station and installed in the 
electrophoresis chamber. Running buffer was added to the chamber and the wells in 
stacking gel were cleaned with a pipette thoroughly before loading the samples. 
 
Sample loading 
Supernatant of cell lysate was loaded in to each well of the stacking gel after 
cleaning of wells. Samples were loaded as shown in Table 4.3. 
 
 
 
 
 
77 
 
Table 4.3.  Volume of samples added to Western blotting gel wells.  
 well1 well2 well3 well4   well5
  
well6
    
well7 well8 
Content Marker 
 
Control         Cancer 
drug 1 
 
Cancer 
drug 2 
 
Ajoene 
 
Combination 
1 
 
Combination 
2 
 
Loading 
sample 
buffer 
Volume Fermentous 
5 µl + 
Magic 2 µl
  
5 µl  10 µl 10 µl 5 µl 10 µl 10 µl  10 µl 
* The volume of lysate added to wells was adjusted depending on the total volumes of 
cell lysates we harvested. After the samples were loaded, electrophoresis was run at 
120 V for 2 hours.  
* Due to the limited amount of spheroids and cell lysate obtained, there was no 
sufficient sample for doing a total protein assay for adjusting the protein 
concentrations. The house keeping protein GAPDH was used as an indicator for 
protein concentration for each group. GAPDH is used as an internal standard protein 
since the expression of GAPDH is constant at different times and after experimental 
manipulations (Mori, Wang, Danenberg, Pinski, & Danenberg, 2008).  
 
Preparation of blocking solution and membrane 
Nitrocellulose membranes were cut the same size as the sponge, and the “transfer 
sandwich” was made as shown in Fig.4.3. 
                       sponge 
                       filter paper 
                       nitrocellulose 
                       filter paper 
                       sponge 
Figure 4.3.  Arrangement of the “Transfer sandwich” for transferring proteins from 
SDS gel to membrane.  
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The layers were immersed in a box of transfer buffer (with 10% methanol) in a 
4
o
C room. When using a PVDF membrane, PVDF was soaked in 95% methanol for 5 
minutes with shaking. The membrane was then washed with milli Q water before it 
was inserted into the filter paper and sponge and soaked in transfer buffer (without 
methanol). 
 
Transfer of protein from the gel to the membrane 
After electrophoresis, the gel holder was disassembled and the gel was placed in 
between the membrane and the filter paper. The layers were placed on the cassette and 
the cassette was sealed after the position of the layers was adjusted. The cassette was 
inserted into the electrophoresis chamber and a piece of ice was put in the chamber. 
The electrophoresis was run at 120 V for 1 hour after the transfer buffer was added. 
 
Blocking and primary antibody binding 
The membrane was carefully removed after the completion of the transfer. The 
membrane was cut to keep the protein and it was soaked in a small container with 10 
ml of blocking solution. The container was then shaken on a shaker at room 
temperature for 1 hour. The blocking solution was varied for different proteins (I.e. 
BSA was used for PARP and ThermoFisher blocking buffer was used for cyclin-D2). 
After the blocking solution in the membrane container was discarded, 10 ml of diluted 
primary antibody (1:1000) was poured into the container and the container was left at 
4
o
C overnight. 
.  
Washing off of the excess antibody, secondary antibody binding and washing 
After the overnight incubation in the primary antibody, the solution in the 
container was discarded. 20 ml of TBS-T was added and the container was shaken on 
a shaker at room temperature for 10 minutes. The TBS-T was discarded after the wash. 
The washing step was repeated 4 times. 13 ml of diluted secondary antibody solution 
(1:5000) was added to the container on the membrane. The container was then shaken 
for 90 minutes. 
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After binding, the solution was discarded and the membrane was washed again in 
the same manner as washing for the primary antibody, finally the membrane was 
washed with 20 ml of milli Q water for 5 minutes at the end. 
 
Developing and imaging 
After the final wash the membrane was taken out of the container and was laid on 
a piece of transparent plastic sheet. Approximately 1 ml of developing solution (GE 
Healthcare ECL plus western blotting detection system, New Zealand) was added to 
each membrane and they were allowed to develop at room temperature for 7 minutes. 
After developing, excess solution was removed and the membrane was covered with 
the other piece of plastic and then ready for imaging. Detection was done with Uvitec, 
Cambridge with Alliance 4.7 software. 
 
 
Frozen sectioning and immunofluorescence 
Cell proliferation and the cytoskeletal protein markers were analysed with 
immunofluorescence experiments. Cell proliferation markers PCNA, p-Akt and 
cytoskeletal proteins tubulin (α) and actin were stained with immunofluorescence 
tagged antibodies using frozen sections of spheroids. 
 
Sample preparation 
Spheroids were harvested from 24 well plates and gathered in eppendorf tubes. 
Spheroids from the same treatment group were combined in the same tube 
respectively. Medium was removed after a brief centrifugation. 0.5 ml of a 50%/50% 
methanol-acetone solution at -20 
o
C was added to each tube. The tubes were kept at 
4°C for further analysis 
 
Spheroids staining and freezing 
The tubes were centrifuged at 2500 rpm for 5 min and the supernatant was 
removed. 1 ml of 1xPBS was added to each tube and the tubes were centrifuged again 
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at 2500 rpm for 5 min. After removal of the PBS, 50 µl of aniline blue (Sigma 
-Aldrich LTD, New Zealand) was added to each tube and the tubes were left in room 
temperature for 20 minutes. 1 ml of water was added to each tube and mixed and the 
tubes were centrifuged at 2500 rpm for 5 minutes. The supernatant was discarded 
after centrifugation. 
The above step was repeated 3 times to wash off the excess color. After washing, 
CryO-Z-T (Ted Pella, INC, USA) was added to the pre-labeled plastic square plate 
and evenly covered the plate area. 1 ml of CryO-Z-T was added to the spheroids in 
each eppendorf tube and spheroids in CryO-Z-T was laid on the CryO-Z-T covered 
plate. Plates were kept at -80°C for further cutting. 
 
Cutting 
Chunks and brushes were kept at -80°C to maintain the temperature of the 
sections. One frozen block of sample was entirely removed from the plastic container 
and fixed on a chunk with CryO-Z-T. Then the sample on chunk was fixed on the 
sample station of cryostat and frozen section with spheroids was cut with microtome 
piece by piece. The pieces were removed with brushes and laid on a pre-labeled clean 
polysine slide (Labserv, New zealand). The slides were kept at -20°C prior to further 
analysis. 
 
Staining frozen section slides with fluorescence tagged antibodies 
Prior to observation, the slides were taken out from -20 °C and left at 4 °C 
overnight. The next day, 300 µl of 1xPBS was added to each slide and the PBS was 
absorbed with paper tissue. Slides were left at 37 °C until completely dry. And then 
superpap pen was used to circle the staining area in order to block the liquid. 300 µl 
of blocking solution was added to each slide and the slides were left at 4 °C for 1 
hour. 
After blocking, 1xPBS was used to wash the slides. 300 µl of 1xPBS was added to 
each slide and the PBS was again absorbed with paper tissue. 300 µl of primary 
antibody (1:200 in dilution solution which was 2% BSA in 1xPBS) was added to each 
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slide. The slides were then incubated at 4 °C overnight.  
The next day, the antibody solution was drawn with paper tissue after incubation, 
and the slides were washed with 1xPBS. The slides were inserted in a slide holder in a 
glass container which was topped up with 1xPBS, with a magnetic stirrer stirring in 
the bottom of the container. 30 minutes later, the PBS was discarded. This washing 
step was repeated once.  
After the PBS was discarded, the slides were taken out and gently dried with 
paper tissue. Secondary antibody solution (1:500 in same dilution solution) was added 
to each slide. The slides were incubated at 37 
o
C for 90 minutes. 
After incubation, 300 µl of 20 µg/ml Hoechst 33342 (Invitrogen, New Zealand) 
was added to each slide and slides were kept in the dark place for 20 minutes. Then 
the slides were washed twice in a glass container with 1xPBS 0.1% tween 20. Slides 
were gently dried after washing and a drop of anti-fading solution 2g/L 
p-phenylenediamine (Sigma -Aldrich LTD, New Zealand) in 80% glycerol was added 
to each slide and the slide was covered with coverslip, slides were observed with an 
epifluorescence microscope (AxioVision 4.5. Apotome software, Carl Zeiss, 
Oberkochen, Germany). 
 
 
Statistical analysis 
Data were statistically analyzed with Prism statistical software using Student’s 
t-test and P<0.05 was used to determine statistical significant. All data were presented 
as mean+SEM.  
 
 
Morphology  
The morphology of spheroids were observed and imaged using transmitted light 
with a Leica stereo microscope 
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Results 
The growth activity and metabolic activity results presented in each section below 
were the combined and analysed results of three independent experiments unless 
otherwise specified. Images of spheroids, immunofluorescence and Western blotting 
shown below were representative photos selected from one of the 3 experiments. 
 
 
Anticancer drug screening  
Growth activities of spheroids treated with paclitaxel and target drugs 
The anticancer drugs sorafenib, everolimus, gefitinib and canertinib were tested 
on Ishikawa spheroids alone and in combination with paclitaxel. In the first round, the 
drugs were added to the spheroids in the manner as shown in Table 4.4. Growth 
activity was analysed with crystal violet assay after the end of the treatment period. 
The results of crystal violet are shown in Fig.4.4 and Fig.4.6. Photos of spheroids 
after treatment are shown in Fig.4.5 and Fig.4.7. 
 
Table 4.4.  Duration and concentration of drug treatment for the target drugs 
screening. 
Treatment Drug concentration Duration 
Paclitaxel 100 nM 4days+2days off+4days 
Sorafenib 2 µM 4days+2days off+4days 
Everolimus 2 µM 4days+2days off+4days 
Gefitinib 2 µM 4days+2days off+4days 
Canertinib 2 µM 4days+2days off+4days 
Combination 100 nM Paclitaxel +2 µM one 
of the other drugs 
4days paclitaxel+2days off+4days 
one of the other drugs 
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The crystal violet assay is a simple assay which is used to determine cell viability. 
Crystal violet (Triphenylmethane dye) stains DNA of cells and the intensity of color, 
which is depending on the amount of the dye taken up by cells, is directly 
proportional to cell number (Vega-Avila & Pugsley, 2011). 
The growth activity of spheroids had a significant reduction in 100 nM paclitaxel 
and 2 μM everolimus treated groups (Fig.4.4), which agreed with sizes of spheroids 
shown on the photos in Fig.4.5.  When everolimus was combined with paclitaxel to 
treat spheroids, the growth activity and spheroid size were reduced even further than 
paclitaxel alone (Fig.4.4 and Fig.4.5), but the further reduction was not statistically 
significant. The VEGFR inhibitor sorafenib alone did not show any inhibitory effect 
over Ishikawa spheroids (Fig.4.4 and Fig.4.5), but its combination with paclitaxel 
gave lower growth activity than control although the result was not statistically 
significant due to the noticeable high variation among experiments.  
A similar pattern was observed in canertinib and gefitinib treatment (Fig.4.6 and 
Fig.4.7). Single use of 100 nM paclitaxel or 2 μM canertinib significantly reduced 
growth activity of spheroids than control, and 2 μM gefitinib alone did not show any 
inhibitory effect on spheroids. The combinations, paclitaxel +canertinib or paclitaxel 
+ gefitinib had significant lower growth activity than control, but the combinations 
were not able to inhibit the spheroids growth further than paclitaxel alone. 
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Figure 4.4.  Growth activities of spheroids treated with various drugs. Growth 
activity was measured by reading the absorbance of crystal violet stained DNA 
solution. Data was normalized by dividing the average absorbance of each treatment 
group by the average absorbance of the control group. Paclitaxel, everolimus and 
paclitaxel+everolimus treated spheroids had significantly reduced growth activity (t 
test, P<0.05), but the difference between single drug and combination groups was not 
significant (t test, P>0.05).  
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Figure 4.5. Images of Ishikawa spheroids after exposure to drugs. Paclitaxel treated 
spheroids had significant smaller spheroids than others treatment and structures of 
spheroids were also more compact than other groups. 
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Figure 4.6.  Growth activity of spheroids treated with various drugs. Data was 
normalized by dividing the average absorbance of each treatment group by the 
average absorbance of the control group. Paclitaxel, canertinib and the combination 
drugs treated spheroids had significantly reduced growth activity (t test, P<0.05), but 
the difference between the single drug treatments and combination groups was not 
significant (t test, P>0.05). 
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Figure 4.7.  Images of spheroids after treatment. Again paclitaxel treated groups had 
significant smaller and more compact spheroids than the control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
88 
 
Effects of everolimus and paclitaxel on Ishikawa spheroids 
In the targeted drugs screening, paclitaxel alone and the combinations showed 
significant inhibitory effects on the growth activity of spheroids. Everolimus alone 
was able to inhibit the growth activity of the cancer cells and it also enhanced the 
effects of paclitaxel (Fig.4.4). In order to further analyze the effects of everolimus and 
its combination with paclitaxel, metabolic activities of spheroids treated with 
paclitaxel, everolimus or the combinations were analyzed using an Alamar Blue assay. 
The concentrations and durations of paclitaxel and everolimus treatments used in 
metabolic activity assessments are listed in Table 4.5. Results and comparisons are 
shown in Fig.4.9.  
 
 
Table 4.5. Duration and concentration of paclitaxel+everolimus treatment for 
metabolic activity experiments. 
Treatment Drug concentration Duration 
Paclitaxel 50 nM 4days treatment+2days off+ 4days 
treatment 
Paclitaxel 100 nM 4days treatment+2days off+ 4days 
treatment 
Everolimus 2 µM 4days treatment+2days off+ 4days 
treatment 
Combination1 50 nM Paclitaxel +2 µM 
everolimus 
4days paclitaxel+2days off+4days 
everolimus 
Combination2 100 nM Paclitaxel +2 µM 
everolimus 
4days paclitaxel+2days off+4days 
everolimus 
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Alamar blue (Resazurin sodium salt) is a colometric REDOX indicator for 
detecting metabolic activity of cells. When cells are proliferating and metabolic 
activity is maintained, a reduced microenvironment is produced and the indicator is 
remains blue. Once the metabolic activity is inhibited, the indicator is oxidized and it 
turns to red (Invitrogen). The absorbance difference at 570 nm and 600 nm represents 
the metabolic activity of cells.  
Before the metabolic activity of drug treated spheroids were measured, metabolic 
activities and diameters of standard spheroids were measured by growing 6 groups 
spheroids on 24 well plates and one group of them was withdrawn from the plates in 
every 2 days. The change of metabolic activity and spheroid diameter are shown in 
Fig.4.8. The figure showed that the pattern of metabolic activity changed by time is 
not the same as the size change. Metabolic activity tended to become stable after a 
certain time of incubation although the sizes of spheroids were still increasing due to 
the expansion of cell numbers in spheroids. Comparison of metabolic activity between 
spheroids treated with different drugs is not going to be significantly affected by the 
size of spheroids.  
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Figure 4.8.  Growth pattern of Ishikawa cell spheroids. The left side Y axis and 
upper graph are representing the diameters of spheroids, and the right side Y axis and 
lower graph are representing the metabolic activity. Metabolic activity was calculated 
through Absorbance 570 nm –Absorbance 600 nm 
 
 
When spheroids metabolic activity was analyzed after treatment, 50 nM 
paclitaxel, 100 nM paclitaxel and 2 µM everolimus treated spheroids had significantly 
lower metabolic activity than the control (Fig.4.9). 50 nM and 100 nM paclitaxel 
treated spheroids did not have significantly different metabolic activity, suggesting 
that the cytotoxic effect of paclitaxel is still high even when the dose was reduced to 
50 nm. When everolimus was used in conjunction with paclitaxel, metabolic activity 
of the spheroids had a further reduction. Again the further reduction was not 
statistically significant due to the relatively high variations among the experiments. 
The metabolic activity experiment results agreed with the growth activity experiments 
of paclitaxel and everolimus. 
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Figure 4.9.  Results of metabolic activity experiments for paclitaxel and everolimus 
treated spheroids. In the paclitaxel and combination groups, paclitaxel was added to 
the spheroids in the first 4 days. Paclitaxel was again added to spheroids in the last 4 
days of the paclitaxel treatment groups whereas everolimus was added to the 
combination groups in the last 4 days. Since the results were Absorbance 570 
nm-Absorbance 600 nm, negative results represent low metabolic activities. Data was 
normalized by dividing the results of treatment groups by the result of the control. 
Drug treated spheroids had significantly lower metabolic activity than the control 
group (t test, P<0.05), but the difference between single treatments and combination 
treatments was not significant. (t test, P>0.05) 
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 Since the growth activity and metabolic activity in paclitaxel+everolimus 
combination groups were not significantly lower than paclitaxel alone treated groups, 
and lower dose paclitaxel still exhibited high inhibitory effects, there is a possibility 
that the cytotoxic effects of the 4 day paclitaxel treatment was too high and the 
growth of spheroids was still inhibited by the earlier paclitaxel treatment in the next 6 
days, thus the effects of everolimus were revealed.  
Therefore, in order to test if everolimus had the ability to maintain and enhance 
the effect of a shorter treatment of paclitaxel, the duration of paclitaxel treatment was 
reduced to 2 days in the second round of crystal violet assays. Comparison was made 
between paclitaxel+everolimus group and the group with only 2 days of paclitaxel 
treatment. Drug doses used in the second round crystal violet experiments are shown 
in Table 4.6. Crystal violet results are shown in Fig.3.10 and images of spheroids are 
shown in Fig. 3.11. 
 
Table4.6.  Duration and concentration of paclitaxel and everolimus for the second 
growth activity experiments. 
Treatment Drug concentration Duration 
Paclitaxel 50 nM 2days treatment+8days off 
Paclitaxel 100 nM 2days treatment+8days off 
Everolimus 2 µM 2days treatment+2days off+6days 
treatment 
Combination1 50 nM Paclitaxel +2 µM 
everolimus 
2days paclitaxel+2days off+6days 
everolimus 
Combination2 100 nM Paclitaxel +2 µM 
everolimus 
2days paclitaxel+2days off+6days 
everolimus 
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 The growth activity pattern remained similar to the previous experiments even 
when the duration of paclitaxel was reduced to 2 days. Spheroids treated with 2 days 
of paclitaxel had significantly reduced growth activity and sizes compared to control, 
even after 8 days of resting period (Fig.4.10 and Fig.4.11). Again the addition of 
everolimus tended to further reduce the growth activity and sizes of paclitaxel treated 
spheroids, but the enhancement of inhibitory effect was not statistically significant. 
 
 
T re a tm e n t
A
b
s
tr
e
a
tm
e
n
t/
A
b
s
c
o
n
tr
o
l
(%
)
c
o
n
tr
o
l
p
a
c
li
ta
x
e
 5
0
n
M
p
a
c
li
ta
x
e
l 
1
0
0
n
M
E
v
e
ro
li
m
u
s
5
0
n
M
 p
a
c
li
ta
x
e
l+
E
v
e
ro
li
m
u
s
1
0
0
n
M
 p
a
c
li
ta
x
e
l+
E
v
e
ro
li
m
u
s
0
5 0
1 0 0
1 5 0
*
*
*
*
*
 
Figure 4.10. Growth activity of spheroids treated with paclitaxel and everolimus. In 
these experiments, the spheroids were only treated with paclitaxel for 2 days in the 
single paclitaxel and combination groups. The spheroids had significantly reduced 
growth activity in all the drug treated groups (t test, P<0.05) but the difference 
between single and combination groups was not significant (t test, P>0.05). 
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Figure 4.11.  Images of spheroids after treatment with the respective drugs. The 
sizes of spheroids in the drug treated groups were smaller than in the control group. 
The 100 nM paclitaxel+everolimus treated spheroids was smaller than the 100 nM 
paclitaxel treated spheroid. Combination groups tended to have noticeably smaller 
spheroids than the corresponding single groups. 
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Antitumor experiments with ajoene 
Paclitaxel and ajoene 
1GE (see chapter 1 garlic extraction) was tested on spheroids alone or with 
paclitaxel and the growth activity of 1GE treated spheroids was assessed by the 
crystal violet assay. Table 4.7 below shows the duration and concentration of 
paclitaxel and ajoene used in this experiment. Fig.4.12 shows the results of crystal 
violet experiments. 
 
Table 4.7.  Duration and concentration of paclitaxel and ajoene treatment for the first 
growth activity experiments. 
Treatment Drug concentration Duration 
Paclitaxel 100 nM 4days treatment+2days off+ 4days 
treatment 
Ajoene 5 µg/ml 4days treatment+2days off+ 4days 
treatment 
Ajoene 10 µg/ml 4days treatment+2days off+ 4days 
treatment 
Combination 100 nM Paclitaxel +5 µg/ml 
ajoene 
4days paclitaxel+2days off+4days ajoene 
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 5 µg/ml and 10 µg/ml of ajoene alone did not inhibit the growth activity of 
spheroids (Fig.4.12). A combination of 5 µg/ml ajoene and paclitaxel reduced the 
growth activity of spheroids further than paclitaxel alone, but this was not statistically 
significant.  
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Figure 4.12.  Growth activities of spheroids treated with paclitaxel and ajoene. 
Ajoene treated spheroids did not show any significant difference from control groups. 
Paclitaxel and the combination groups had lower results than the control. Treatments 
using combinations tended to inhibit spheroid growth activity further than using 
paclitaxel alone. The paclitaxel and combination groups had significantly reduced 
growth activities (t test, P<0.05) but the difference between these two groups was not 
significant (t test, P>0.05). 
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Again, in order to exclude the possibility that the inhibitory effects were solely 
due to the prior paclitaxel treatment, the duration and dose of paclitaxel and ajoene 
treatment was altered in the second round of experiments. Besides growth activity, 
metabolic activity, cell proliferation, cytoskeletons and apoptotic activities were also 
analyzed for the spheroids. 3GE and 4GE (see chapter1 garlic extraction) was used in 
this round of experiments. 
 
Table 4.8.  The duration and concentration of paclitaxel and ajoene used in second 
round of antitumor experiments. 
Treatment Drug concentration Duration 
Paclitaxel 50 nM 4days treatment+6days off 
Paclitaxel 100 nM 4days treatment+6days off 
Ajoene 10 µg/ml 4days treatment+2days off+4days 
treatment 
Combination1 50 nM paclitaxel +10 µg/ml 
ajoene 
4days paclitaxel+2days off+4days 
ajoene 
Combination2 100 nM paclitaxel +10 µg/ml 
ajoene 
4days paclitaxel+2days off+4days 
ajoene 
 
Growth activity, metabolic activity and sizes of spheroids did not show any 
significant change in the 10 µg/ml ajoene treated groups (Fig.4.13, Fig.4.14 and 
Fig.4.15). Four days of 50 nM or 100 nM paclitaxel alone treated groups had 
significantly reduced growth activity, metabolic activity and sizes. Addition of 10 
µg/ml ajoene for the later 4 days of treatment after paclitaxel did not bring any further 
reduction in growth activity, metabolic activity and sizes of spheroids.  
Immunofluorescent staining of the cell proliferation markers PCNA and p-Akt 
was elevated in single paclitaxel and paclitaxel+ajoene treated spheroids (Fig.4.18 and 
Fig.4.19). Ajoene alone enhanced PCNA but not p-Akt expression (Fig.4.18 and 
Fig.4.19).  
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Immunofluorescent images of the cytoskeletal protein tubulin showed higher 
expression of tubulin in paclitaxel and ajoene treated groups than the control 
(Fig.4.16). The pattern of actin staining did not show significant difference among 
groups (Fig.4.17).  
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Figure 4.13.  Growth activities of spheroids treated with paclitaxel and ajoene. 
For these experiments paclitaxel was only added to the single paclitaxel treatment 
groups in the first 4 days and spheroids were left untreated for the rest of the 
incubation time. Again 10 µg/ml ajoene treated spheroids did not have any significant 
difference from control groups. The single drug paclitaxel groups and combination 
groups had significantly reduced growth activities compared to the control (t test, 
P<0.05) but the difference between the correspondent single and combination groups 
was not significant (t test, P>0.05). 
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Figure 4.14.  Results of metabolic activity (Alamar Blue) experiments for paclitaxel 
and ajoene treated spheroids. In the paclitaxel and combination groups, paclitaxel was 
only added to the spheroids for the first 4 days. Then spheroids were left untreated in 
the single paclitaxel group whereas ajoene was added to the combination groups in 
the last 4 days. Again negative results represent low metabolic activities. 10 µg/ml 
ajoene treated spheroids did not show any significant reduction in metabolic activity. 
Paclitaxel containing groups had significantly lower metabolic activity than the 
control group (t test, P<0.05). Combinations of paclitaxel and ajoene groups tended to 
have lower metabolic activities than their correspondent single paclitaxel groups but 
the difference was not significant. (t test, P>0.05) 
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Figure 4.15. Images of spheroids treated with paclitaxel and ajoene. 10 μg/ml ajoene 
treated spheroids did not have any reduction in size. Paclitaxel involved groups had 
significantly reduced spheroids sizes and the structures of spheroids in these groups 
were compacter than control and ajoene groups.  
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Figure 4.16. Immunofluorescent images of tubulin in frozen cut sections of spheroids 
treated with paclitaxel and ajoene. Tubulin was stained green and nuclei were stained 
blue.  
 
 
Figure 4.17. Immunofluorescent images of actin in frozen cut sections of spheroids 
treated with paclitaxel and ajoene. Actin was stained green and nuclei were stained 
blue.  
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Figure 4.18. Immunofluorescent images of p-Akt in frozen cut sections of spheroids 
treated with paclitaxel and ajoene. P-Akt was stained red and nuclei were stained 
blue.  
 
 
Figure 4.19. Immunofluorescent images of PCNA in frozen cut sections of spheroids 
treated with paclitaxel and ajoene. PCNA was stained green and nuclei were stained 
blue.  
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Figure 4.20.  Results of a Western blotting for GAPDH, PCNA, Akt and p-Akt of 
spheroids treated with paclitaxel and ajoene. PA stands for paclitaxel on this Fig.. 
Several attempts were made using spheroids from each individual experiment. The 
results above were the best images from all of the attempts. Since the spheroids were 
tiny and volume of protein solution added to Western blotting wells were limited, 
there was not enough protein to be shown on the PCNA, Akt AND p-Akt western 
blotting images. The Housekeeping protein GAPDH bands appeared on the image but 
this protein from paclitaxel and combination treated groups was not enough to be 
clearly displayed. As such conclusive result could be generated from this western 
blotting result. 
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Everolimus and ajoene 
Everolimus was tested along with paclitaxel in the antitumor drug screening 
experiments stated in the earlier paragraphs. The drug has shown its ability to inhibit 
the growth and metabolic activities of spheroids. In order to investigate any 
additive/synergistic effect between everolimus and ajoene, spheroids were treated 
with ajoene, everolimus and their combinations, and growth activity, metabolic 
activity, cell proliferation, cytoskeletons and apoptotic activities was analyzed with 
crystal violet assay, Alamar Blue, frozen section immunofluorescence staining and 
western blotting. The duration and doses of everolimus and ajoene used in this round 
of experiments are listed in Table 4.9. 
 
Table 4.9. The Duration and doses of everolimus and ajoene used in antitumor 
experiments  
Treatment Drug concentration Duration 
Everolimus 1 µM 4days treatment+2days off+ 4days 
treatment 
Everolimus 2 µM 4days treatment+2days off+ 4days 
treatment 
Ajoene 10 µg/ml 4days treatment+2days off+4days 
treatment 
Combination1 1 µM Paclitaxel +10 µg/ml 
ajoene 
4days everolimus+2days off+4days 
ajoene 
Combination2 2 µM Paclitaxel +10 µg/ml 
ajoene 
4days everolimus+2days off+4days 
ajoene 
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Growth activity and metabolic activity of spheroids did not show any significant 
change in everolimus and ajoene treated groups (Fig.4.21 and Fig.4.22). The size of 
spheroids was reduced in 2 µM everolimus and 2 µM everolimus+ajoene treated 
groups (Fig. 4.23).  
Immunofluorescent staining and an immunoblotting of the cell proliferation 
marker PCNA was slightly elevated in everolimus and ajoene treated groups 
(Fig.4.26), and p-Akt was elevated in everolimus but not the ajoene treated groups 
(Fig.4.25). Western blot results showed that the cell cycle marker cyclin D2 was 
elevated by everolimus and ajoene (Fig.4.28).  
Immunofluorescent images of the cytoskeletal proteins tubulin and actin did not 
show significant difference among groups (Fig.4.27 and Fig.4.24). The apoptotic 
marker cleaved caspase 3 protein at 17 kDa was not shown by any group on Western 
blotting results, but PARP (Poly ADP ribose polymerase) and cleaved PARP was 
observed in everolimus treated groups on western blotting image (Fig.4.28).  
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Figure 4.21. Growth activities of spheroids treated with everolimus and ajoene. 
Everolimus involved groups tended to have lower growth activities than control, but 
the differences among groups are not significant. (t test, P>0.05) 
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Figure 4.22. Results of metabolic activity experiments for everolimus and ajoene 
treated spheroids. Differences among groups are not significant. (t test, P>0.05) 
 
 
 
Figure 4.23. Images of spheroids treated with everolimus and ajoene. Spheroids had a 
reduction in size in the 2 µM everolimus and 2 µM everolimus +ajoene groups. 
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Figure 4.24. Immunofluorescent images of actin in spheroids treated with everolimus 
and ajoene. Actin was stained green and nuclei were stained blue.  
 
 
 
 
Figure 4.25.  Immunofluorescent images of p-Akt in spheroids treated with 
everolimus and ajoene. P-Akt was stained red and nuclei were stained blue. 
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Figure 4.26. Immunofluorescent images of PCNA in spheroids treated with 
everolimus and ajoene. PCNA was stained green and nuclei were stained blue.  
 
 
 
Figure 4.27. Immunofluorescent images of tubulin in spheroids treated with 
everolimus and ajoene. Tubulin was stained green and nuclei were stained blue.  
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Figure 4.28.  Results of Western blotting for GAPDH, PCNA, cyclin D2, caspase 3, 
Akt, p-Akt and PARP from spheroids treated with everolimus and ajoene. There was 
no band visible for caspase 3 and Akt. The housekeeping protein GAPDH bands 
appeared and suggesting the relative amount of protein in each group. “EV” stands for 
everolimus and “AJ” stands for ajoene. 
 
 
 
 
 
 
. 
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Discussion 
Growth activities of spheroids treated with paclitaxel and targeted drugs 
Sorafenib has been suggested to be a multikinase inhibitor. It inhibits several 
kinases including Raf-1, tyrosine kinase receptors and vascular-endothelial growth 
factors (VEGF). It has shown inhibitory effects on endometrial cancer previously 
using a monolayer cell culture. Liobet’s group treated Ishikawa cell monolayers and 
endometrial carcinoma tissue monolayers with sorafenib for 24 or 48 hours, and they 
found that sorafenib was able to induce cytotoxicity and mitochondrial apoptosis to 
the cancer cells in a dose and time dependent manner (Llobet et al., 2010). Gefitinib is 
a small molecule inhibitor of EGFR, and it binds to the ATP binding site of the EGFR 
kinase domain and inhibits the activation of the growth factor and results in the 
inhibition of cell proliferation (Fig. 4.1). It has shown therapeutic effects on various 
cancer cells, which have an active EGFR pathway (Albitar et al., 2007; Dedes et al., 
2011). Albitar’s group suggested that Ishikawa cells with PTEN mutations are more 
sensitive to gefitinib than the cells with a p53 mutation (Albitar et al., 2007). Recently, 
Meng’s group xenotransplanted human endometrial cancer cells on mice and cells 
were withdrawn from mice after growth. Gefitinib and paclitaxel was then tested on 
the tumor cells in vitro on monolayers. Gefitinib alone does not show significant 
effect on the cells but addition of gefitinib reduces the IC50 of paclitaxel from 14.7 nM 
to 1.3 nM (Meng et al., 2013).  
In our study, a 3D spheroid culture of Ishikawa cells with p53 and PTEN 
mutation was used in sorafenib and gefitinib treatments, and neither of these two 
drugs showed an inhibitory effect on growth of Ishikawa spheroids, nor any 
synergistic effect with paclitaxel. Previous studies suggested that the secretion of 
VEGF was highly suppressed in Ishikawa 3D spheroids and the influence of EGFR on 
cell growth was reduced in 3D cell cultures (Chitcholtan et al., 2013). Down regulated 
EGFR and reduced EGFR inhibitor efficacy is observed in 3D culture of colorectal 
cancer cells (Luca et al., 2013). The reduced VEGF and EGFR influence in 3D 
spheroids may be an explanation of the resistance to VEGF and EGFR inhibitors 
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sorafenib and gefitinib. 
 EGFR activity can be activated and enhanced by HER-2 overexpression and the 
inhibition of HER-2 together with EGFR can result in greater inhibition of tumor 
growth than inhibition of EGFR alone (Reid, Vidal, Shaw, & de Bono, 2007). 
Canertinib is an irreversible inhibitor and it has inhibitory activity over both EGFR 
and HER-2 (Rabindran, 2005). It is able to induce apoptosis on breast cancer cell lines 
which overexpresses HER-2 (Nelson & Fry, 2001).  
 In our results, canertinib was able to reduce the growth activity of 3D Ishikawa 
spheroids alone. There was no evidence on synergy between cancertinib and 
paclitaxel treatment. The inhibitory effect of canertinib on the 3D culture of spheroids 
may suggest that inhibition of both EGFR and HER-2 is more effective on 3D 
endometrial cancer culture than inhibition of EGFR alone. 
Everolimus targets the mTOR, which is the downstream growth factor of Akt.  
Akt/mTOR is described as a pair of master switch proteins of cell metabolism and 
proliferation, and mTOR is also suggested to be apoptosis inhibitor (Castedo, Ferri, & 
Kroemer, 2002). Inhibition of mTOR by everolimus results in blockage of cell cycle 
of lymphocyte cell lines in G1/S phase and apoptosis (Majewski et al., 2000). 
Everolimus has been tested on HEC-1A endometrial adenocarcinoma cell monolayers 
in 96 well plates and shown inhibitory effect on cell growth (Treeck, Wackwitz, Haus, 
& Ortmann, 2006). When everolimus is combined with cytotoxic drug cisplatin to 
treat A549 human non-small cell lung carcinoma cells in 96 well plates, the sensitivity 
of cancer cells to cisplatin is increased 10 fold by everolimus (Beuvink et al., 2005). 
In this study, everolimus was able to reduce the size, growth activity and 
metabolic activity of 3D Ishikawa spheroids which had dysfunctioning PTEN. The 
result agreed with the previous findings that everolimus inhibited both PTEN mutant 
Ishikawa cell monolayers and xenograft tumors (Shoji et al., 2012), and oral intake of 
everolimus showed beneficial results in phase II clinical trials for treating endometrial 
carcinoma (Slomovitz et al., 2010). However, the synergistic effect between paclitaxel 
and everolimus was not significant which may due to the distinct pattern of signaling 
and cell-cell interactions in 3D culture from 2D culture used in the previous study 
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(Beuvink et al., 2005).  
 
Effects of ajoene and paclitaxel on Ishikawa spheroids 
 Size (Fig.4.15), growth activity (Fig.4.13) and metabolic activity (Fig.4.14) of 
ajoene treated Ishikawa cell spheroids did not show any reduction when compared to 
control groups. PCNA but not p-Akt immunostaining was slightly elevated in ajoene 
and paclitaxel treated groups (Fig.4.18 and Fig.4.19). PCNA is an auxiliary protein of 
DNA polymerase C and is important in the initiation of cell proliferation. It is mostly 
used as a marker for evaluation of proliferative activity in cut sections of tumors 
(Alka & Kumar, 2012). Phosphorylated and activated Akt leads to inhibition of 
apoptosis and PI3K/Akt/mTOR pathway is up-regulated in PTEN mutated 
endometrial cancer cells (Church, Koppensteiner, Yap, Fink, & Dedes, 2012). The 
status of Akt may serve as a prognostic marker and the inhibition of PI3K/Akt 
signaling pathway (Kim et al., 2006). Therefore, these results suggested that ajoene 
did not inhibit growth of Ishikawa cells and possibly promoted the proliferation of 
Ishikawa spheroids. The Akt pathway might not be involved in the promotion of cell 
proliferation by ajoene.  
In this study, immunostaining of cytoskeletal protein actin did not show any 
significant change in ajoene treated spheroids and α-tubulin expression was slightly 
elevated in ajoene treated spheroids. The cytoskeletal proteins are important for 
cellular morphology and structure maintenance. Microtubules which are formed by 
tubulin assembly are essential for intracellular transport, metabolism and cell division. 
Previous studies on pancreatic cancer cell 3D culture suggested that cytoskeleton 
protein actin formed less stress fibers in 3D nanoculture and tubulin expression was 
higher in 3D culture than in 2D culture (Matsuda et al., 2010). Ajoene is thought to be 
able to inhibit the assembly of microtubules (Li et al., 2002). When ajoene is used to 
treat 2D culture of leukemic cell line U937 cells in 96 well plates, expression of 
β-tubulin is increased by ajoene and the expression of α-tubulin is not altered (Li, Shi, 
Wang, Min, & Cui, 2004). However, in our study, the response of cytoskeletal 
proteins to ajoene treatment may indicate an inter-cell line difference and the effects 
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of ajoene on microtubules may not be significant in the 3D spheroid model.  
Size (Fig.4.15), growth activity (Fig.4.13) and metabolic activity (Fig.4.14) of 
paclitaxel treated Ishikawa cell spheroids were significantly reduced. These results 
agreed with the previous reports of in vitro and clinical trials on treating endometrial 
cancers with paclitaxel (Ball, Blessing, Lentz, & Mutch, 1996; Vilos et al., 2013; C. 
Xu et al., 2011). Unfortunately, the proliferation markers could not be detected by 
Western blotting assay due to the significantly reduced cell number in spheroids. 
When the spheroids were treated with paclitaxel, cell number and spheroid size were 
very low and there was not enough proteins to be detected by western blotting assay 
since the volume of cell lysate added to SDS gel was limited. In future study, it will 
be necessary to increase the concentrations of proteins in cell lysates for loading. 
Strong PCNA and p-Akt staining was observed in the cells of the spheroids 
treated with paclitaxel. These cells have shown strong proliferating ability thus 
suggested that these cancer cells would be able to divide and reproduce again once the 
paclitaxel treatment is stopped. This results agreed with the findings that the 
reoccurrence of endometrial cancer is frequent in the treatment-free interval of 
paclitaxel treatment (Markman et al., 1999).   
Actin staining was not altered in paclitaxel treated groups but strong tubulin 
staining was observed in paclitaxel treated groups. Polymerized β-tubulin is believed 
to be the binding site of paclitaxel and paclitaxel kills tumors by inhibit the 
disassembly of microtubules. More effective paclitaxel treatment is suggested in 
tubulin overexpressed cancers (Roque et al., 2013). The high expression of tubulin in 
Ishikawa spheroids could have resulted in the response to paclitaxel treatment.  
There was no synergistic effect found between ajoene and paclitaxel. However, 
the antitumor effects of paclitaxel were not interrupted by ajoene (Fig.4.13- Fig.4.15). 
Intake of ajoene may be beneficial in other aspects of health such as antimicrobial 
effects (see chapter 2), and it does not bring disadvantage when patients are treated 
with paclitaxel.  
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Effects of ajoene and everolimus on Ishikawa spheroids 
Again, ajoene alone did not show inhibitory effect on spheroids but increased the 
PCNA expression. There was no apoptotic marker (PARP and caspase-3) detected by 
Western blotting assay in ajoene treated spheroids, suggesting that ajoene alone might 
not induce apoptosis to Ishikawa spheroids.  
Levels of the cytoskeletal proteins actin and tubulin were not altered by 
everolimus (Fig.4.24 and Fig.4.27). PCNA and p-Akt were slightly elevated in 
everolimus treated groups in both immunofluorescent and Western blotting results 
(Fig. 4.25, Fig.4.26 and Fig.4.28). The remaining cells in the spheroids treated with 
everolimus still appeared to be proliferating. mTOR is the downstream of Akt, and 
everolimus which inhibits mTOR1 is suggested to be able to activate mTOR2 and 
increase the phosphorylation of Akt in 2D culture of small intestinal neuroendocrine 
tumor cells. Therefore, everolimus treatment can be affected by the activation of Akt 
(Svejda et al., 2011). The elevation of p-Akt by everolimus in our study may provide a 
clue for the moderate effect of everolimus on Ishikawa spheroids. But in order to 
confirm this, Akt level should be determined together with p-Akt level in any further 
study.  
Cyclin D2 was increased by everolimus as shown on the Western blotting 
(Fig.3.28). D-type cyclins are a group of highly conserved cell cycle regulators and 
cyclin D2 is an important regulator of cell cycle progression from the G1 phase to S 
phase (Witt et al., 2013). The reason why the cell cycle progression was unregulated 
is unclear, but it may also suggest that the remaining survival cells in the spheroids 
are proliferating and quickly progressing through their cell cycles.  
The apoptotic markers PARP and cleaved PARP were present on the Western 
blotting of everolimus treated spheroids but there was no caspase 3 shown (Fig.4.28). 
PARP catalyzes the poly(ADP-ribosyl)ation of nuclear proteins and its substrate was 
suggested to be NAD. PARP contributes to cell death by depleting NAD and ATP. 
Cleavage of PARP occurs when cell apoptosis is induced by drug treatment and this 
cleavage is believed to be mostly done by caspase 3, which is a central apoptotic 
mediator (Boulares et al., 1999). Therefore, cleavage of PARP should accompanied by 
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the activation of caspase 3. We did not detect any cleaved caspase 3 and this may be 
due to the low amount of proteins present in cell lysates.  
Again there was no synergistic effect found between ajoene and everolimus since 
ajoene did not significantly further inhibit the everolimus treated spheroids. Intake of 
ajoene may be beneficial in other aspects of health as ajoene did not interrupt the 
treatment when spheroids were treated with everolimus.  
 
 
Conclusion 
 The targeted drugs sorafenib and gefitinib did not show inhibitory effect or 
synergistic effect with paclitaxel on 3D spheroids of Ishikawa cells. Canertinib was 
able to inhibit growth activity of Ishikawa spheroids but it was not synergistic with 
paclitaxel. Everolimus was able to inhibit the growth and metabolic activity of the 
spheroids and induce apoptosis but its synergistic effect with paclitaxel was not 
significant. 
 Ajoene alone did not inhibit growth of 3D spheroids, and it did not induce cell 
death. Paclitaxel showed strong anticancer activity over 3D Ishikawa cell spheroids 
but the survival cells showed strong proliferation ability. There was no synergistic 
effect detected between ajoene and paclitaxel or between ajoene and everolimus. 
Intake of ajoene is still beneficial as it did not interrupt paclitaxel or everolimus 
treatment. 
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Appendix 
Appendix 4.1.  Components of 10xPBS 
Components Amount 
Na2HPO4 7.1g 
NaH2PO4 For pH adjustment 
NaCl 45g 
KCl 1g 
Water 500ml 
 
 
 
Appendix 4.2.  Components of solutions used in western blot experiments. 
 
Components of RIPA lysis buffer  
components concentration 
Tris-HCl pH7.4 50mM 
NaCl 100mM 
EDTA 5mM 
NP-40 1% 
SDS 0.10% 
Sodium deoxycholate 0.50% 
Na3VO4 1mM 
Glycerol 10% 
Protease inhibitor tablet 1 tablet in 50ml 
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Loading sample buffer   
Content 1M 
Tris-HCl 
pH6.8 
50%glycerol 10% SDS 1% 
bromophenol 
blue 
Water 
Volume 0.6ml 5ml 2ml 1ml 1.4ml 
 
 
10% or 12% SDS gel solution 
Content 40% 
Acylamide 
0.8% 
bis-acylamide 
solution B 
(75%  
2M Tris-HCl 
pH 8.8 + 
4%SDS) 
10% 
ammonium 
persulfate 
TEMED Milli Q 
water 
Volume(10%) 4.995ml 3.75ml 75ul 7.5ul 6.255ml 
Volume(12%) 4ml 2.5ml 50ul 5ul 3.5ml 
 
 
7% stacking gel solution  
Content 40% 
Acylamide 
0.8% 
bis-acylamide 
solution C 
(50% 1M Tris-HCl  
pH 6.8 + 4%SDS) 
10% 
ammonium 
persulfate 
TEMED Milli Q 
water 
Volume 1ml 1ml 40ul 5ul 2ml 
 
 
Running buffer  
Content Tris Glycine SDS Milli Q water 
Mass or Volume 3g 14.4g 1g 1L 
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TBS-T 
Content Tris-HCl pH7.5 NaCl 0.7% tween 20 
Concentration or Volume 20mM 140mM 0.1%v/v 
 
   
Transferring buffer  
Content Tris Glycine Milli Q water 
Mass or Volume 1.93g 9g 1L 
 
 
Blocking solution 
Blocking solution varied in different protein detection. There were 3  types of 
blocking solution used in this study. They were: 5% skim milk in TBS-T, 4% BSA 
(Bovine serum albumin, Sigma-Aldrich LTD, New Zealand) in TBS-T or 
ThermoFisher blocking solution (ThermoFisher scientific LTD, New Zealand). 
 
 
 
 
 
 
 
 
 
 
 
 
119 
 
Appendix 4.3. Protein antibodies used in western blot and immunofluorescence 
experiments. 
Protein antibody Origin 
GAPDH Santa Cruz Biotechnology, CA, USA 
PCNA Santa Cruz Biotechnology, CA, USA 
AKT Santa Cruz Biotechnology, CA, USA 
p-AKT Santa Cruz Biotechnology, CA, USA 
Cyclin D2 Santa Cruz Biotechnology, CA, USA 
Caspase 3 Santa Cruz Biotechnology, CA, USA 
PARP Santa Cruz Biotechnology, CA, USA 
Alpha-tubulin Sigma LTD, New zealand 
Actin 
anti-Mouse IgG-HRP 
anti-Rabbit IgG-HRP 
Anti-mouse FITC    
Anti-rabbit 594  
Santa Cruz Biotechnology, CA, USA 
Sigma -Aldrich LTD, New Zealand 
Sigma -Aldrich LTD, New Zealand 
Sigma -Aldrich LTD, New zealand 
Sigma -Aldrich LTD, New zealand 
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Final conclusions 
 We successfully extracted ajoene from 3 of the 4 independent garlic extractions. 
The position of ajoene on the thin layer chromatography was confirmed in the first 
and third extraction and this provided a clue for ajoene detection in the further 
extractions. In the second extraction, ajoene was not able to be eluted off from the 
flash chromatography column. The size of column and pressure used in the flash 
chromatography were concluded to be crucial for successful separation and elution. 
 Antifungal activity of ajoene was shown against the yeast and germ tube form of 
Candida albicans. Radial extension and individual hyphal extension of a filamentous 
fungus Neurospora crassa and an oomycete Achlya bisexualis were also inhibited by 
ajoene. The possible targets of ajoene are suggested to be either the cell membrane or 
the microtubules (Li et al., 2002; Naganawa et al., 1996; San-Blas et al., 1997), and 
cysteine residues are thought to be oxidized during the reaction and played a crucial 
part in ajoene’s bioactivity (Jacob et al., 2012; Kaschula et al., 2012; Naganawa et al., 
1996).  
The extent of which Neurospora crassa responded to ajoene was higher than that 
for Achlya bisexualis. The reason is possibly due to the distant phylogenetic 
relationship between Neurospora crassa and Achlya bisexualis (Richards et al., 2006), 
since cell membrane composition and microtubule sequence may vary between these 
species (Mu et al., 1999; Tylicki et al., 2012).  
 Ajoene did not show any antitumor effect on 3D Ishikawa spheroids. No 
additional or synergistic effect was detected when ajoene was combined with 
paclitaxel or everolimus to treat 3D Ishikawa spheroids. The signaling, growth pattern 
and cell differentiation are significantly different when cancer cells are growing in a 
3D culture (Chitcholtan et al., 2013). Drug resistance has been suggested to occur in 
3D cancer cultures (Longati et al., 2013). Although ajoene has been suggested to be 
able to inhibit growth of various cancer cell lines in vitro and in vivo (Dirsch et al., 
1998; Taylor et al., 2006; B. Xu et al., 2004), the 3D Ishikawa spheroids were found 
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to be resistant to ajoene treatment.  
 Similar patterns were noticed with the targeted drugs sorafenib and gefitinib 
(drugs which target VEGF and EGFR) treatments, which did not show any inhibitory 
effect on 3D Ishikawa spheroids. The reduced influence of VEGF and EGFR in 3D 
cancer cell cultures possibly resulted in the observed drug resistance (Chitcholtan et 
al., 2013). Additional inhibition of HER-2 together with EGFR showed inhibitory 
effects on 3D Ishikawa spheroids when the spheroids were treated with canertinib. 
The mTOR inhibitor everolimus was able to inhibit the growth of PTEN mutated 
Ishikawa spheroids, suggesting that the PTEN mutated, mTOR enhanced cell line was 
susceptible to mTOR inhibitor treatment. However, the synergistic effect between 
everolimus and cytotoxic drug was not significant, due to the different cell line and 
cell model used from the previous studies.  
 In conclusion, the garlic extract ajoene was successfully extracted from fresh 
New Zealand garlic and it was able to inhibit the growth of C.albicans, N. crassa and 
A. bisexualis. On 3D Ishikawa spheroids, ajoene showed neither an inhibitory effect 
nor any synergistic effect with other drugs. The targeted drugs exhibited varied effects 
on ajoene, and the effects of the targeted drugs were influenced by the 3D cell model. 
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